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LINK BETWEEN MUSCLE AND WHOLE-BODY ENERGETIC RESPONSE TO 
EXERCISE 
MAY 2021 
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Directed by: Professor Jane A. Kent 
Substantial evidence exists regarding how skeletal muscles use energy and how 
this affects muscular performance. What remains unclear is how characteristics of muscle 
energetics affect whole-body energetics during daily living, and what effects this may 
have on mobility. The goal of this study was to determine the associations between 
muscle and whole-body energetics including the relationships between: 1) muscle PCr 
depletion (∆PCr) in response to light intensity isotonic contractions and the oxygen 
deficit at the onset of a 30-min treadmill walk (30MTW), and, 2) muscle oxidative 
capacity and excess post-exercise oxygen consumption (EPOC; 30MTW), respiratory 
exchange ratio (RER; 30MTW), and peak oxygen consumption (VO2 peak) from a 
graded treadmill test. Eight healthy young (28.4 ± 3.5 years) male participants were 
studied. Muscle energetics were measured via 31-Phosphorus magnetic resonance 
spectroscopy (31P-MRS). Muscle ∆PCr was determined as the change in PCr during 2-
min of isotonic knee extensor contractions. Muscle oxidative capacity was determined as 
the rate constant (kPCr) of a PCr recovery following 24-s of maximal isokinetic knee 
extensor contractions. Whole-body energetic responses to the 30MTW were measured 
via indirect calorimetry. Oxygen deficit and EPOC were determined as the time constants 
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of the change in oxygen consumption at the onset and offset of the 30MTW, respectively. 
Respiratory exchange ratio was determined as the mean RER during minutes 7-30 (RER 
L23), 25-30 (RER L5), and 29-30 (RER L1). Peak oxygen consumption was the highest 
30-s average of oxygen consumption during a graded treadmill test, normalized to total 
mass and lean mass measured by dual-X-ray absorptiometry. Spearman rank correlation 
coefficients (rs) were calculated to evaluate the associations between independent 
variables (muscle ∆PCr and oxidative capacity) and dependent variables (oxygen deficit, 
EPOC, RER, and VO2 peak). Muscle ∆PCr had a positive association (rs = 0.46, p = 0.30) 
with oxygen deficit. Muscle oxidative capacity had a negative association with EPOC (rs 
= -0.64, p = 0.14), RER L23 (rs = -0.64, p = 0.14), L5 (rs = -0.68, p = 0.11), and L1 (rs = -
0.74, p = 0.07). Muscle oxidative capacity had a positive association with VO2 peak per 
lean mass (rs = 0.64, p = 0.10), but not VO2 peak per total mass (rs = 0.14, p = 0.75).  
These results provide promising preliminary evidence that muscle energetics are 




Table of Contents 
ACKNOWLEDGMENTS ................................................................................................ IV 
ABSTRACT ....................................................................................................................... V 
LIST OF TABLES ............................................................................................................ IX 
LIST OF FIGURES ........................................................................................................... X 
CHAPTER 
1. INTRODUCTION .......................................................................................................... 1 
Presentation of the Problem ........................................................................................................................ 1 
Background ................................................................................................................................................. 3 
ATP: The Primary Energy Source .......................................................................................................... 3 
31P-MRS: A Window into Muscle ATP Production ............................................................................... 5 
Indirect Calorimetry: A Window into Whole-body Energetics .............................................................. 7 
Connecting Muscle to Whole-body Energetics ......................................................................................... 10 
Oxygen Deficit ..................................................................................................................................... 10 
Maximal Oxygen Consumption ............................................................................................................ 11 
Excess Post-exercise Oxygen Consumption ......................................................................................... 11 
Substrate Use ........................................................................................................................................ 11 
The Gap in Knowledge and Proposed Solution ........................................................................................ 12 
Specific Aims ............................................................................................................................................ 13 
2. LITERATURE REVIEW ............................................................................................. 15 
Introduction of Measurements .................................................................................................................. 15 
31Phophorus Magnetic Resonance Spectroscopy .................................................................................. 15 
Oxidative Capacity………………………………………………………………………………….................. 22 
Indirect Calorimetry ............................................................................................................................. 25 
Non-Oxidative ATP Flux ………………………………………………………………………………….......24 
VO2 Max …………………………………………………………………………………..................................31 
O2 Deficit ………………………………………………………………………………….................................32 
Excess Post-Exercise Oxygen Consumption ………………………………………………………………..33 
Substrate Use …………………………………………………………………………………...........................35 
Measurement Comparison .................................................................................................................... 37 
Problem to be Addressed and Proposed Solution ..................................................................................... 38 
Problem to be Addressed ...................................................................................................................... 38 
Proposed Solution ................................................................................................................................. 42 
The Advantages of Whole-body Energetic Measures........................................................................... 42 
The Relationship between Muscle and Whole-body Energetics ........................................................... 47 
Summary ................................................................................................................................................... 49 
3. METHODS ................................................................................................................... 50 
Study Overview ........................................................................................................................................ 50 
Participants ................................................................................................................................................ 51 
Meals .................................................................................................................................................... 52 
Descriptive Data........................................................................................................................................ 52 
Physical Activity Monitoring ............................................................................................................... 52 
Anthropometrics and DXA Scan .......................................................................................................... 53 
Whole-body Metabolic Measures ............................................................................................................. 53 
Treadmill Walk. .................................................................................................................................... 53 
viii 
 
VO2 Peak Measures ............................................................................................................................. 54 
Muscle Bioenergetics ................................................................................................................................ 55 
Magnetic Resonance Measures ............................................................................................................. 55 
Oxidative Capacity ............................................................................................................................... 57 
Ramp Contraction Protocol .................................................................................................................. 57 
Kinetic Analysis ........................................................................................................................................ 58 
Statistics .................................................................................................................................................... 59 
4. RESULTS ..................................................................................................................... 61 
Participant Characteristics......................................................................................................................... 61 
Whole-body Metabolic Responses to 30MTW ......................................................................................... 61 
Room Calorimeter Measurements. ....................................................................................................... 61 
Treadmill Walk. .................................................................................................................................... 62 
Metabolic Variables During the 30MTW. ............................................................................................ 62 
Respiratory Exchange Ratio. ................................................................................................................ 63 
On- and Off- Kinetics for Metabolic Variables. ................................................................................... 65 
VO2 Peak. .............................................................................................................................................. 67 
Muscle Bioenergetic Variables ................................................................................................................. 69 
Oxidative Capacity ............................................................................................................................... 69 
Non-Oxidative ATP Production ........................................................................................................... 70 
Associations Between Single Muscle and Whole-body Energetics .......................................................... 72 
5. DISCUSSION ............................................................................................................... 77 
Muscle and Whole-body Non-oxidative Energy Use are Related at the Onset of Exercise ...................... 78 
Muscle and Whole-body Oxidative Energy Use are Related .................................................................... 80 
Muscle Oxidative Capacity is Associated with EPOC ......................................................................... 80 
Muscle Oxidative Capacity is Associated with RER ............................................................................ 82 
Muscle Oxidative Capacity was Associated with the Mean RER from the Entire Steady-state  .......... 82 
Muscle Oxidative Capacity was Associated with VO2 Peak Relative to Lean Mass  .......................... 83 
Limitations ................................................................................................................................................ 85 
Summary ................................................................................................................................................... 86 
APPENDICIES 
A. INFORMED CONSENT FORM ................................................................................. 89 
B. PARTICIPANT SCREENING FORM ...................................................................... 100 
C. VO2 PEAK TEST PROTOCOL ................................................................................. 106 
D. PARTICIPANT 7 EPOC FIT DATA ADJUSTMENT FOR PHONE USE ............. 107 
E. CORRELATION COEFFICIENTS AND P-VALUES FROM PEARSON’S, 
SPEARMAN’S, AND KENDALL’S TESTS ................................................................ 108 





LIST OF TABLES 
Table 1. Comparison of 31P-MRS and Indirect Calorimetry Measures ............................ 38 
Table 2. Participant characteristics ................................................................................... 61 
Table 3. Treadmill walk metabolic variables .................................................................... 63 
Table 4. Individual RER values from the 30MTW ........................................................... 65 
Table 5. Oxygen deficit variables ..................................................................................... 67 
Table 6. EPOC variables ................................................................................................... 67 
Table 7. VO2 peak values from the ramp treadmill protocol ............................................ 69 
Table 8. Oxidative capacity individual fit variables ......................................................... 70 
Table 9. Variables from fit of ∆PCr .................................................................................. 72 




LIST OF FIGURES 
Figure 1. Experimental set up for 31P-MRS analysis of muscle energetics. ....................... 2 
Figure 2. Study focus .......................................................................................................... 2 
Figure 3. Maximal energy rates and availability from different pathways. ........................ 4 
Figure 4. Oxygen consumption response to moderate-intensity exercise. .......................... 8 
Figure 5. 31P-MRS spectrum from resting muscle. ........................................................... 17 
Figure 6. Labeled structure of ATP .................................................................................. 17 
Figure 7. The chemical shift in ATP Adapted from. ........................................................ 18 
Figure 8. Change in concentrations of phosphorus metabolites as detected by 31P-MRS.
.................................................................................................................................. .19 
Figure 9. The chemical shift of various relevant phosphate compounds as a function of 
pH .............................................................................................................................. 20 
Figure 10. Muscle energetics responses to exercise, A) followed by ischemia, B) in 
response to various work rates. ................................................................................. 22 
Figure 11. Mechanisms of phosphate transfer in the cell. ................................................ 23 
Figure 12. Time course for the rates of PCr depletion a), glycolysis b), and oxidative 
metabolism c), in skeletal muscle at three different workloads. ............................... 24 
Figure 13. The relationship between direct and indirect calorimetry. .............................. 26 
Figure 14. Stoichiometry of carbohydrate and fat catabolism. ......................................... 26 
Figure 15. Methods of indirect calorimetry ...................................................................... 27 
Figure 16. Physiological adaptations that lead to an improvement in VO2 max .............. 32 
Figure 17. Oxygen consumption in response to exercise over time ................................. 33 
Figure 18. Visualization of EPOC fast component (Phase 1) and slow component (Phase 
2) ............................................................................................................................... 35 
Figure 19. a.) Gas exchange at the cells and lungs; b.) Caloric values of O2 and CO2 for 
non-protein RQ and proportions of substrate used ................................................... 36 
Figure 20. Crossover point and the effect of training. ...................................................... 37 
Figure 21. The mechanistic pathway connecting aging, muscle energetics, mobility, and 
health outcomes.. ...................................................................................................... 39 
Figure 22. The proposed framework for physiological interactions that lead to decreases 
in mobility-related function. ..................................................................................... 42 
Figure 23. A-B) Oxygen deficit and EPOC in unimpaired and impaired older women, 
respectively, C) Pearson’s correlations between aerobic measurements and mobility 
test performance.  ...................................................................................................... 45 
Figure 24. The simultaneous response of VO2 and PCr kinetics to different intensity 
constant rate exercise ................................................................................................ 48 
Figure 25. Study Visit Overview ...................................................................................... 51 
Figure 26: Magnetic Resonance Spectroscopy Protocol .................................................. 56 
Figure 27: Representative plot of metabolic data from 30MTW. ..................................... 63 
Figure 28. Individual RER values from the 30MTW ....................................................... 64 
Figure 29. Representative fits of data showing (A) oxygen deficit and (B) EPOC. ......... 66 
Figure 30. Individual oxygen deficit and EPOC time constants from the 30MTW ......... 66 
xi 
 
Figure 31. Representative data from the ramp treadmill protocol .................................... 68 
Figure 32. Individual VO2 peak values from the ramp treadmill protocol ....................... 68 
Figure 33: Representative monoexponential fit of PCr recovery data from the oxidative 
capacity protocol ....................................................................................................... 69 
Figure 34. Individual oxidative capacity rate constants. ................................................... 70 
Figure 35. Representative fit of changes in PCr during stage 1 of ramp protocol. ........... 71 
Figure 36. Individual ∆PCr during stage 1 of ramp protocol ........................................... 71 
Figure 37. Association between oxygen deficit and ∆PCr ............................................... 73 
Figure 38. Association between EPOC and muscle oxidative capacity ........................... 73 
Figure 39. Associations between RER during the 30MTW and muscle oxidative capacity
................................................................................................................................... 74 
Figure 40. Association between VO2 Peak normalized to total mass and lean mass and 
oxidative capacity ..................................................................................................... 75 
Figure 41. Pathway connecting muscle energetics to mobility-related function .............. 87 







Presentation of the Problem 
Mobility can be defined as the ability to move freely and easily. A decline in 
mobility-related function (i.e., the capacity to complete mobility tasks) poses a significant 
threat to the quality of life in multiple segments of the population, including those who 
are elderly, diseased, or disabled (27, 35, 85). Many physiological systems contribute to 
mobility, but the production of movement is the primary function of skeletal muscle. In 
particular, skeletal muscle converts chemical energy into mechanical energy, which 
enables muscles to contract and create bodily motion. To produce and sustain movement, 
muscle energy production must increase several orders of magnitude above its resting 
level. This high energy requirement makes adequate energy production vital to mobility 
(103). The general study of how organisms derive and use energy is termed 
bioenergetics. Bioenergetic research, as it relates to movement, is often performed at 
either the muscle (in vitro, in situ, or in vivo) or the whole-body level (24, 29, 30, 34, 49, 
71, 78, 97, 108). The study proposed here will evaluate both. 
Historically, our lab has used 31phosphorus magnetic resonance spectroscopy (31P-
MRS) to investigate the effects of aging and physical activity on muscle energetics and 
fatigue in vivo, with the goal of improving mobility and increasing quality of life. We 
have demonstrated that aging and physical activity are related to altered muscle oxidative 
capacity (36, 70), glycolytic flux (66, 69), and the accumulation of fatiguing metabolites 
(66, 69). Although it is clear that muscle energetics are important for mobility, 
determining the effect of altered muscle energetics on mobility-related function proves 
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difficult. This is largely because the most effective way to measure muscle energetics, 
31P-MRS, is limited to the confines of a magnetic resonance scanner and cannot be used 
during mobility tasks (Fig. 1). One potential solution lies in the measurement of whole-
body energetics, which can be completed during mobility tasks, and is related to indices 
of mobility-related function (4, 9, 15, 92, 98, 99). Whole-body energetics is largely 
dependent on muscle energy demand (21, 93, 94, 110), and could potentially act as an 
intermediate pathway through which muscle energetics affects mobility-related function 
(Fig. 2). Therefore, the goal of this project is to analyze the relationship between muscle 
and whole-body energetics; during the completion of and recovery from daily-living type 
exercise. 
 








ATP: The Primary Energy Source 
Energy cannot be created or destroyed, only transferred. In living organisms, 
chemical energy is transferred into mechanical energy to complete tasks such as 
contracting muscle. Humans derive this chemical energy from food; the majority comes 
from carbohydrate and fat sources and a small portion comes from protein (106). These 
three substances are considered macronutrients and serve as substrates for energy-
producing chemical reactions (energy metabolism). The amount that each substrate 
contributes to energy production is termed substrate use. Through the breakdown of 
macronutrients, the body generates adenosine triphosphate (ATP), which is a small 
molecule that can both store and transfer chemical energy. Energy transferred through 
ATP is used by the body to transmit signals, transport ions, contract muscles, build and 
breakdown substances, and drive chemical reactions, among other functions.  
To release energy from ATP, one of the three phosphates is cleaved off by an 
enzyme, producing adenosine diphosphate (ADP) and inorganic phosphate (Pi) and 
releasing energy as a byproduct. Phosphate-cleaving enzymes (ATPases) can serve many 
functions, and how the released energy is used depends on the enzyme involved. In 
muscle, for example, myosin acts as an ATPase by splitting ATP and using the energy 
released to complete a “powerstroke” causing muscle to contract. Without ATP, vital 
enzymes would not be able to complete their functions and living organisms would 
quickly perish. Thus, the production of ATP is one of the most important processes of the 
human body (90). 
There are three main pathways through which ATP is generated: the 
phosphocreatine (PCr) system, glycolysis, and oxidative metabolism (consisting of the 
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Krebs cycle and oxidative phosphorylation). The first two pathways can generate energy 
without the use of oxygen and are collectively referred to as non-oxidative metabolism. 
Conversely, oxidative metabolism can only occur when oxygen is available. Cells rely on 
different pathways based on their needs, function, structure, and enzymatic makeup. In 
human cells, non-oxidative metabolism occurs in the cytoplasm and oxidative 
metabolism occurs in the mitochondria. All three energy pathways contribute to ATP 
generation at all times, however, the relative contribution of each varies due to 
differences in rate, duration, and the conditions under which they can provide energy 
(55). As shown in Fig. 3 the maximal rate of ATP generation and the amount of ATP that 
can be derived from the body’s energy stores differs for each pathway. 
 
Figure 3. Maximal energy rates and availability from different pathways. (55)  
 
 The PCr system consists of a single-step reaction that transfers a phosphate from 
PCr to ADP, resulting in the synthesis of ATP and creatine (Cr). Cells have limited stores 
of PCr (~15 s worth), but the simplicity of the reaction allows for very rapid energy 
production (Fig. 3). 
Glycolysis is a slightly more complex process involving ten chemical reactions 
that break down carbohydrate (glucose or glycogen) into smaller intermediate molecules 
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eventually producing pyruvate, NADH (an energy shuttle), and ATP. Only the ATP can 
be used directly for energy, while the pyruvate and NADH can be sent into the 
mitochondria for use in oxidative metabolism. For this reason, glycolysis is a non-
oxidative source of ATP). The amount of energy that can be produced by glycolysis from 
carbohydrate stores is more than that from the PCr system (Fig. 3) but is still only 
sufficient for short-duration exercise (~1 min). The rate of glycolytic ATP generation is 
slower than the PCr system but faster than oxidative metabolism (Fig. 3).  
Oxidative metabolism is made up of two multi-step processes; the Krebs cycle 
and oxidative phosphorylation. The products of either glycolysis or beta-oxidation (the 
breakdown of fat) enter the Krebs cycle and oxidative phosphorylation where they are 
further metabolized, eventually producing ATP, carbon dioxide (CO2), and water. 
Oxidative metabolism generates ATP at a slower rate than the PCr system or glycolysis; 
however, it can use carbohydrate, fat, or protein as substrates. For this reason, the 
duration that ATP can be produced oxidatively from the body’s substrate stores is on the 
order of days. Oxidative metabolism also generates the largest amount of ATP per 
substrate consumed- roughly 15-52 times that of glycolysis depending on the substrate 
used- making it the most efficient in terms of energy per gram of fuel (55). 
31P-MRS: A Window into Muscle ATP Production 
In skeletal muscle, the rate that PCr, glycolysis and oxidative metabolism produce 
ATP can be observed using 31P-MRS. This technique is a non-invasive method that uses 
radio waves in the presence of a static magnetic field to determine the concentration of 
31P-containing chemical compounds within the body. Typical 31P-MRS measurements 
include quantitation of: ATP flux through each pathway, oxidative capacity (i.e., 
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maximal rate), metabolic economy, and intracellular acidification in response to muscle 
contractions. A muscle’s ability to generate force and power over time is dependent on 
adequate energy production, from sustainable pathways, for the entirety of the exercise.  
Analysis of energetics has shown that at the onset of exercise (muscle 
contractions) muscle first relies on the PCr system to provide immediate energy. Muscle 
stores of PCr decline at a rate relative to the energy demand and would quickly deplete 
without the additional contribution from the other two systems. Glycolysis will assist first 
because the rate of energy production can be increased rapidly to meet energy demands. 
At low-moderate intensity, after there has been enough time for its rate to increase, 
energy reliance will then shift mainly to oxidative metabolism. At higher intensities, 
glycolysis will continue to provide the majority of energy, because oxidative metabolism 
cannot produce ATP at a sufficient rate (47, 102, 103). However, high rates of glycolysis 
are also associated with increased muscle fatigue (decrease in force or power production) 
and are therefore likely to shorten the duration that contractions can be performed (108). 
After contractions cease, PCr stores that were depleted at the onset of exercise will be 
replenished by ATP generated through oxidative metabolism. A muscle’s oxidative 
capacity can be estimated by measuring the rate of PCr recovery after a PCr-depleting 
bout of exercise (57). This is a measure of the muscle's maximal ability to generate 
energy through oxidative metabolism and is dependent on mitochondrial content, quality, 
enzyme content, as well as muscle capillary density, and oxygen (O2) perfusion. After 
exercise, other metabolites that accumulated during the contractions (H+, ADP, and Pi) 
will also return to baseline levels; hence this period is referred to as recovery (81, 87). 
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Indirect Calorimetry: A Window into Whole-body Energetics 
Indirect calorimetry is a respirometry technique that estimates energy expenditure 
via measurement of O2 and CO2 expired from the lungs. This gas exchange is 
representative of the O2 consumption and CO2 production of the entire body because all 
blood is eventually circulated to the lungs to allow gas exchange with air from the 
environment. In contrast to the muscle level, analysis of whole-body energetics through 
the use of indirect calorimetry allows for the evaluation of oxidative energy production 
only. Currently, there are no direct methods to determine the contribution of the PCr or 
glycolytic pathways to whole-body energy expenditure. Common variables assessed 
using indirect calorimetry include: the energetic cost of a task, oxygen uptake kinetics at 
exercise onset (“on” kinetics), oxygen uptake kinetics at the end of an exercise (“off” 
kinetics), and substrate use throughout exercise (grams oxidized per substrate). Similar to 
the measurement of muscle oxidative capacity, graded exercise tests can be used to 
determine the maximal rate of oxidative metabolism at the whole-body level (VO2 peak). 
The same traits associated with high oxidative capacity in muscle are also associated with 
smaller and shorter O2 deficits (on kinetics) and excess post-exercise oxygen 
consumptions (EPOCs; off kinetics) and increased use of fats during higher-intensity 
exercise (90). 
At the beginning of a given exercise bout, energy demand increases 
instantaneously to a level dependent on the activity. Oxidative energy production, 
however, cannot increase instantaneously and will slowly rise to meet energy demand. 
The difference between the actual O2 consumption and the amount required to meet 
demand is termed the O2 deficit (Fig. 4). While in a state of O2 deficit, the non-oxidative 
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pathways (PCr and glycolysis) provide the remainder of energy needed to perform the 
task.  
 
Figure 4. Oxygen consumption response to moderate-intensity 
exercise. (32)  
At low-moderate exercise intensities, oxidative energy production will eventually 
meet demand and O2 consumption will plateau. This is called steady-state, during this 
time the energy systems have reached equilibrium, and oxidative metabolism is assumed 
to be the main provider of energy (Fig. 4) (40). Once a steady-state is reached, the rate of 
carbohydrate and fat use can be estimated, as can energy cost of the activity (kcals). At 
high exercise intensities, oxidative energy production is never able to fully meet demand, 
and oxygen consumption will not plateau. This is not considered steady-state and the 
relative contribution of each pathway is unclear.  
Post-exercise recovery is the process of the body returning to homeostasis. During 
recovery from exercise, oxygen consumption (and therefore energy expenditure) remains 
elevated above resting levels for a period of time even though the direct energy demand 
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of the exercise has ceased. This period is called the EPOC and can be broken into a fast 
(initial rapid decrease in O2 consumption) and a slow (prolonged low-level elevation of 
O2 consumption) component (Fig. 4). The excess O2 consumed during the fast component 
is believed to contribute to the replenishment of hemoglobin and myoglobin oxygen 
stores (within seconds) and the oxidative regeneration of PCr to resting levels (within 
minutes). The excess O2 consumed during the slow component is believed to be required 
due to the residual elevation in ventilation and heart rate, lactate’s oxidation or 
conversion to glucose, glycogen re-synthesis, an increased rate of metabolism due to 
elevated temperature and catecholamine levels, re-establishment of ionic equilibrium, and 
potentially an increased protein turnover (38, 40). 
There are two primary modes of indirect calorimetry; measurement of gas 
exchange by a metabolic cart or by a room calorimeter (also referred to as a metabolic 
chamber). Metabolic carts can allow for breath-by-breath analysis of respiration and 
therefore have a very fine temporal resolution. This technique requires the participant to 
wear a mask or a mouthpiece connected to a stationary cart or a backpack, which can be 
cumbersome, and uncomfortable. This makes them unsuitable for detecting small, long-
duration changes in metabolism, and are typically only used for short-term analyses (<3 
hr). Room calorimeters have a lower temporal resolution but do not require the use of 
masks or bulky equipment. In a room calorimeter, the participant is able to eat meals, 
exercise, and sleep while gas exchange is measured continuously. This allows for long-




Connecting Muscle to Whole-body Energetics 
While the energetics of a single muscle can be observed through 31P-MRS, 
movement requires the energetic contributions of multiple muscles and physiological 
systems. Together, the energy requirements of muscular, cardiovascular, neural, and 
respiratory components of the body contribute to the cost of physical activity energy 
expenditure. However, muscle makes up 20-30% of energy expenditure at rest and up to 
90% during exercise, and therefore, should have a large impact on metabolic variables 
observed during whole-body energy expenditure (110). The vastus lateralis (VL), a large 
muscle located on the anterior-lateral portion of the thigh, is one of the more common 
muscles studied using 31P-MRS. The VL helps to extend the leg at the knee and plays an 
important role in ambulation during both the swing and support phase of gait (22, 76). It 
is activated during gait in a similar manner to the vasti medialis and intermedius, which 
contribute to gait increasingly as walking speed increases and make up the majority of the 
quadriceps muscles (76, 86). Due to the VL’s significant role in ambulation, its energetic 
characteristics are likely to affect whole-body energy expenditure during mobility tasks. 
Oxygen Deficit 
At the onset of exercise, during the O2 deficit, non-oxidative sources must 
compensate for the difference between energy demand and oxidative energy supply. 
While it is not currently possible to quantify the non-oxidative contribution at the whole-
body level, it is possible to estimate non-oxidative ATP production in a single muscle. If 
an individual’s VL has a high reliance on non-oxidative pathways and is slow to increase 
oxidative energy production, then it is likely to coincide with a greater oxygen deficit 
during whole-body exercise that relies heavily on the VL and like muscles.  
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Maximal Oxygen Consumption 
The maximal rate of oxidative energy production can be measured at both the 
single muscle and whole-body levels as oxidative capacity and VO2 max, respectively. 
Maximal oxygen consumption is approached during forms of exercise that require 
significant work from a large amount of muscle mass. Therefore, it is likely that the 
oxidative capacity of large muscles such as the VL would have a considerable impact on 
an individual’s VO2 max, which has been demonstrated previously (111). 
Excess Post-exercise Oxygen Consumption 
During recovery, extra energy (above resting) is required to return the body to 
homeostasis; this energy is produced via oxidative metabolism. This process can be 
observed at the whole-body level through the measurement of EPOC, a significant 
portion of which allows for the re-synthesis of muscle PCr. Therefore, a high muscle 
oxidative capacity may enable faster recovery from exercise and a shorter EPOC (63). 
Substrate Use 
Although 31P-MRS can be used to measure the rate of oxidative energy 
production it cannot be used to determine substrate use (fat vs. carbohydrate use). 
However, substrate use can be estimated with indirect calorimetry using the respiratory 
exchange ratio (RER). Studies of substrate use during exercise have shown that at low 
intensities the body relies more on fat as an oxidative fuel source, but shifts to 
carbohydrates use as intensity increases (51). This occurs because carbohydrates can be 
used by oxidative pathways at a faster rate than fat. Studies have also shown that 
aerobically trained individuals will continue to rely on fat at higher relative and absolute 
intensities than their untrained counterparts (4). The same adaptations that occur with 
aerobic training, an increase in mitochondrial and capillary density, are also responsible 
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for increases in muscle oxidative capacity. Individuals with a greater oxidative capacity 
may then be more reliant on fat at any given intensity.  
The Gap in Knowledge and Proposed Solution 
Researchers have suggested that both single-muscle and whole-body energetics 
affect free-living daily function through changes in fatigue, fatigability, mobility, and 
physical activity (4, 9, 23, 24, 30, 92, 97-99, 108). While connections between muscle 
and whole-body energetic characteristics may appear relatively straightforward, few 
studies have attempted to evaluate the connection between the two in a comprehensive 
manner that is applicable to free living. One study by Rossiter et al. (93) measured 
muscle and whole-body energetics simultaneously during rhythmic alternating knee 
extensions. A direct association was shown between energy consumption measured at the 
muscle and whole-body level. However, the isolated non-ambulatory exercise used in the 
Rossiter et al. study is significantly different from normal activities of daily living. 
Another study by Hunter et al., in 2006, attempted to relate muscle metabolic function to 
free-living energy expenditure and physical activity. This study used a combination of 
room calorimetry and doubly-labeled water for estimation of free-living energy 
expenditure and activity levels. However, the precise physical activities, their time 
course, and the characteristics of O2 deficit, substrate use, and EPOC could not be 
analyzed, as only the sum of two weeks of energy expenditure was recorded (48). To the 
best of the author’s knowledge, a study has yet to be performed that evaluates the 
connection between high-resolution, whole-body energetics during free-living activities 
and muscle energetic characteristics during contractions of comparable intensity. 
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To fully understand the impact of alterations in muscle energetics on mobility-
related function, their relation to whole-body energetics during mobility activities must 
be determined. For this reason, this study will consist of a comprehensive analysis of 
muscle and whole-body energetic responses to exercise, and then evaluate potential links 
between them. Completion of this project will advance the field by providing evidence 
that whole-body energetics can be used as a reliable intermediary point between muscle 
energetics and mobility-related function. 
Specific Aims 
With the above stated, the aims of the proposed research are: 
Aim 1. Evaluate the relationships between muscle ∆PCr in response to light intensity 
(6% MVIC) isotonic contractions and the O2 deficit at the onset of a standardized 
treadmill walk. 
 
Hypothesis 1. There will be a positive association between muscle ∆PCr and O2 
deficit because reliance on non-oxidative energy sources (∆PCr) is and indicator that the 
ATP need not being met through oxidative metabolism. Therefore, those who rely more 
on PCr likely do so because it takes longer for them to increase oxidative energy 
production to meet demand at exercise onset (O2 deficit). 
 
Aim 2. Evaluate the relationships between muscle oxidative capacity and; EPOC and 
RER in response to a treadmill walk, and VO2 peak from a graded maximal exercise test.  
 
Hypothesis 2.1. There will be a negative association between muscle oxidative 
capacity and EPOC because a greater ability to produce energy oxidatively will result in 
less depletion of PCr and creation of lactate at the start of exercise, and, faster repletion 
of PCr and oxidation of lactate following exercise, both of which should result in a 
shorter EPOC time constant. 
 
Hypothesis 2.2. There will be a negative association between muscle oxidative 
capacity and RER because a greater ability to produce energy oxidatively would 
decrease the relative intensity of a standardized exercise, and, is related to an increased 
ability to use fat as a fuel source, both of which are related to a greater reliance on fat 
and therefore a lower RER. 
 
Hypothesis 2.3. There will be a positive association between muscle oxidative 
capacity and VO2 peak because they are indicators of the maximal ability of the muscle’s 
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and the whole-body to consume oxygen, and muscle consumes the majority of the body’s 





 LITERATURE REVIEW 
 The purpose of this thesis is to connect two common forms of bioenergetic 
analysis in a way that will be useful in future research in the realm of aging, physical 
inactivity, and mobility-related function. Because the primary goal is to provide strong 
evidence of the relationship between energetic characteristics measured at the muscle and 
the whole-body levels, it is necessary that the techniques used, as well as their 
physiological significance, are understood. For this reason, this literature review will start 
with a relatively in-depth review of the methods and measurements that are the focus of 
this study. This review will be followed by a more succinct review of the literature 
regarding this study’s motivation and justification. 
Introduction of Measurements 
31Phophorus Magnetic Resonance Spectroscopy  
 Magnetic resonance spectroscopy (MRS) is a method that that takes advantage of 
sub-atomic nuclear properties to determine the chemical composition of a given sample 
without the need to physically disrupt it or interfere with its function (i.e., noninvasively). 
Discussed here is 31Phosphorus-MRS (31P-MRS) as it is used in human bioenergetic 
research to determine the concentration of 31P containing chemical compounds within the 
body. Analysis of these compounds allows for the observation of energy production and 
consumption in the body. There are many metabolically important 31P containing 
chemicals in the body, but the ones most commonly measured are inorganic phosphate 
(Pi), phosphocreatine (PCr), and adenosine triphosphate (ATP). During human 31P-MRS, 
a participant is put inside a magnetic resonance scanner where they are exposed to a 
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strong static magnetic field, and radio wave signals are sent into the body. The energy 
from these radio waves will be absorbed by 31P atoms, which will then re-emit signals 
that can be detected by the scanner. These signals are emitted at specific frequencies, 
called resonant frequencies. Different frequency signals will be emitted based upon the 
characteristics of the molecule that the 31P atom is bound to. The amount of signal at a 
certain frequency is based on the amount of a particular chemical in the sample, and it is 
from these signals that chemical concentrations are derived.  
The output of this technique is a graph with frequency on the x-axis and 
amplitude on the y-axis. Peaks at different frequencies represent the 31P signal from 
specific molecules and the amplitude of each peak represents the relative concentration of 
that molecule. This graph is known as a spectrum and an example can be seen in Fig. 5. 
In this spectra obtained from skeletal muscle peaks for Pi, PCr, and ATP are easily 
observable. There are three peaks for the ATP signal because there are three 31P atoms in 
ATP, each of which resonates at a slightly different frequency due to its position and 





Figure 5. 31P-MRS spectrum from resting muscle. (57)  
 
Figure 6. Labeled structure of ATP (Wikimedia Commons) 
 
The use of 31P-MRS to investigate phosphorus-containing chemicals began in 
1960 when Cohn and Hughes successfully observed multiple 31P peaks in solutions of 
both ADP and ATP. In the same study, they also demonstrated an important 
characteristic of MRS known as a chemical shift. A chemical shift is a change in the 
resonance frequency of an atom due to a change in the chemical environment, which in 
this case was altered pH. As seen in Fig. 7, when exposed to extremely low pH (3.60), the 
alpha (ά) and gamma (γ) 31P peaks in ATP shift to both resonate at a similar frequency 
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and appear to merge into one signal. Measurement of particular chemical shifts in 31P-
MRS signals became of great importance in the years to follow (25). 
 
Figure 7. The chemical shift in ATP Adapted from. (25) 
 
 In the 1970s scientists began using 31P-MRS to investigate biological tissue (77). 
By the mid 70’s Burt and colleagues (among others) brought the technique to the study of 
excised intact skeletal muscle, where they were able to resolve clear peaks for Pi, PCr, 
and the three phosphates of ATP, as well as several other metabolites. Since these 
experiments were conducted in live intact muscle, it became possible to observe how the 
concentration of metabolites changed over time, greatly increasing the efficacy of using 




Figure 8. Change in concentrations of phosphorus 
metabolites as detected by 31P-MRS. (16) 
 
Through several titration experiments, it was also observed that Pi had a 
significant chemical shift across a physiologically relevant pH range (7.5 – 6.0 pH), but 
PCr and ATP did not (Fig. 9). This was an important discovery because it showed that the 
chemical shift of Pi could be used to accurately estimate the pH of intact muscle without 
the need for invasive measurements. The concept of which is as follows; because a 
change in pH across a normal physiological range causes a consistent and repeatable 
change in the resonance frequency of Pi, that resonance frequency can then be used to 




Figure 9. The chemical shift of various relevant phosphate 
compounds as a function of pH Adapted from (16) 
 
 In 1978 Dawson, Gadian and Wilkie pioneered techniques that allowed them to 
investigate the energetics of muscle fatigue (i.e., a decline in force production) in 
contracting muscle. By attaching a strain gauge to a sample of excised frog muscle inside 
a spectrometer (an MRS device) and stimulating it with electrodes, they completed one of 
the first 31P-MRS analyses of live contracting muscle. From this, the energetic cost of 
force development was calculated and it was found that muscle fatigue was proportional 
to H+ and ADP accumulation, but not to decreases in ATP or PCr. This suggested that 
muscle fatigue was likely due not to a lack of available energy, but rather inhibition 
caused by the buildup of metabolites. It was also observed that as less force was produced 





economy of ATP hydrolysis is relatively stable. These findings demonstrated the 
potential power of 31P-MRS and helped set the stage for years of muscle fatigue research 
to follow (28). A large breakthrough was made two years later by Ackerman et al. when 
they created an instrument called a ‘surface coil’ which when used in conjunction with 
standard MRS equipment greatly enhanced spatial resolution. Until this point, it was not 
possible to select a region of interest when scanning a sample, meaning that to study a 
specific tissue or organ it would first have to be removed from the organism. Utilizing 
this new tool Ackerman et al. became the first team to obtain 31P-MRS spectra in animal 
muscle and brain in vivo. This breakthrough was of great importance because it opened 
the door for the use of MRS techniques in human muscle without the need for any 
invasive procedures (e.g., biopsies) (1). In the years since methods have continued to 
improve and MRS has become one of the most important tools used in the study of 
human bioenergetics.  
Work with MRS has allowed scientists, in the words of Doris Taylor, to “define 
those features of muscle metabolism that are relatively invariant in healthy subjects” to 
enable the “diagnosis and understanding of different disorders of the locomotor system” 
(102). Some of these important features include the following. At the beginning of 
submaximal exercise PCr concentrations in muscle decline proportionally to work rate, 
but will reach a steady-state with a similar time constant (Fig. 10 B.) (6, 81). The rate of 
glycolysis will increase to assist in ATP production during contraction but not does 
contribute significantly to ATP or PCr synthesis during recovery (91, 102). Intracellular 
pH will decrease more with increasing work intensities and in relation to an increased 
rate of glycolysis (6, 17, 103). The creatine kinase (CK) reaction is maintained near-
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equilibrium during submaximal contractions, which allows for the calculation of ADP 
concentrations (6, 103). Oxidative energy production is the major source of energy during 
light steady-state exercise and is solely responsible for the re-synthesis of PCr after 
exercise (Fig. 10 A.) (91, 102). 
 
Figure 10. Muscle energetics responses to exercise, A) followed by ischemia, B) 
in response to various work rates. A) The 4 lower curves represent the intracellular 
pH of four participants. The upper top curve represents the PCr changes in 
participants 1-3 (open circle) and 4 (closed circle). B) Each curve represents the PCr 
response to repetitive muscle stimulation at increasing intensity representing 0.25, 
0.50, and 0.75 Hz (A: (34), B: (38)). 
 
 With the knowledge of these and other basic features of skeletal muscle 
metabolism researchers have developed several measures that vary across subjects and 
can be used as indicators of energetic function. The two measures that are important to 
this study’s aims are muscle oxidative capacity and non-oxidative ATP flux and are 
discussed further here.  
Oxidative Capacity 
 Muscle oxidative capacity is a measure of the maximal rate of oxidative ATP 
production by the mitochondria. For this reason, muscle oxidative capacity can serve as a 
measure of mitochondrial function. Indeed, a higher oxidative capacity is associated with 
endurance training and physical activity and is likely a result of increased mitochondrial 
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content and oxidative enzyme activity (70). During exercise, PCr acts as a cellular buffer 
to transiently maintain ATP concentrations until demand can be met by glycolysis or 
oxidative metabolism. To complete this PCr donates a phosphate to ADP producing ATP 
and free creatine. In times of low energy demand, free creatine is then used to 
resynthesize PCr with the donation of a phosphate from oxidatively generated ATP, (Fig. 
11). 
 
Figure 11. Mechanisms of phosphate transfer in 
the cell. (20) 
 
Oxidative capacity is estimated using PCr recovery rate after a bout of 
contractions that decrease its concentration by ~50%, without altering pH or ATP levels. 
This is based on the observation that PCr is replenished after exercise almost exclusively 
by the oxidative pathway and follows a monoexponential trajectory (81, 91, 102). The 
use of this 31P-MRS measurement of mitochondrial function has been validated against in 
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vitro respiration measures and when applied appropriately is both accurate and precise 
(67, 72). 
Non-Oxidative ATP Flux 
 As previously stated, any time that oxidative energy production cannot meet 
demand the non-oxidative energy pathways will generate the remainder of ATP needed. 
This is particularly important during the onset of exercise due to the slow response time 
of oxidative metabolism, as seen in see Fig. 12 (54). 
 
Figure 12. Time course for the rates of PCr depletion a), 
glycolysis b), and oxidative metabolism c), in skeletal muscle 
at three different workloads. (54) 
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This flux of ATP is proportional to the intensity of the exercise and the time 
constant for the rise in oxidative metabolism (54). Non-oxidative ATP flux is contributed 
to by both the PCr and glycolytic pathways. The rate of non-oxidative metabolism is 
important as higher rates are associated with greater fatigue and slower recovery (28, 
103). The generation of ATP from PCr can be measured directly from the change in 
concentration of PCr. Glycolytic ATP generation is estimated using its stoichiometric 
relation to proton (H+) production. Proton production is measured using the chemical 
shift as discussed earlier (16, 28, 102). A portion of the protons generated from glycolysis 
is either excreted from the cell or buffered by intracellular chemicals. This means that the 
pH of the muscle does not fully reflect the proton generation and an additional calculation 
must be used to account for the proton buffering capacity of the cell (28). Many different 
methods exist for these calculations so they are not included here. 
Indirect Calorimetry 
 Humans derive energy through a series of reactions that release stored energy 
from the chemical bonds in the food they consume. During this process, whether it be 
oxidative on non-oxidative, heat is produced. Direct calorimetry is the measurement of 
this heat production, which is proportional to the summed energy expenditure from 
oxidative and non-oxidative metabolism. Due to this, direct calorimetry can be used in 
biological research to measure the energy expenditure of various organisms and has been 
applied to the study of human energetics since the 18th century. The basis for a direct 
calorimeter is simple. It is a device (usually a sealed chamber) that measures the change 
in temperature of its contents. However, the implementation of these devices is far more 
complex. Direct calorimeters that can be used for human research must be rather large 
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and are expensive, low in temporal resolution, and have limitations that make them 
undesirable for the study of exercise. An alternative technique for human metabolic 
analysis is indirect calorimetry. Indirect calorimetry is a method that uses measurements 
of O2 gas consumption and CO2 gas production to estimate energy expenditure (Fig. 13).  
 
Figure 13. The relationship between direct and 
indirect calorimetry. (56)  
 
As mentioned earlier, all human energy is originally derived from food and the 
breakdown of this food releases energy and heat. An important aspect of this breakdown 
(catabolism) is that when energy is derived oxidatively, a specific amount of O2 is 
consumed and CO2 is produced, depending on the substrate that is involved (particularly 
carbohydrate or fat). The amount of energy expended as well as the food source that it 
comes from can then be calculated using measurements of gas exchange by observing the 
sum and the ratio of O2 consumed to CO2 produced (Fig. 14).  
 
Figure 14. Stoichiometry of carbohydrate and fat catabolism. 





Compared to direct calorimetry this method is less expensive, has better time 
resolution, and can be used to estimate energy expenditure during exercise as well as the 
amount of carbohydrate and fat used (i.e., substrate use). Indirect calorimetry equipment 
measures the gas exchange between an organism’s lungs and the environment and may 
come in the form of masks, ventilated hoods, and whole-room chambers (Fig. 15). A 
major drawback of indirect calorimetry is that it only measures energy expenditure 
related to oxidative metabolism, although the size of the O2 deficit can be used to 
estimate relative the contribution of non-oxidative metabolism. Despite this, it is 
currently the most popular calorimetric technique used to analyze human energy 
metabolism (56). 
 
Figure 15. Methods of indirect calorimetry. From left to right Hans-Rudolph 
mask, ventilated hood, whole-room chamber. 
 
Indirect calorimetry was developed during the early 1800s and was validated 
against direct calorimeter in animal studies. While the basis of indirect calorimetry is 
slightly more complex than direct calorimetry, most information gained from this 
technique comes from three outputs: volume of O2 consumed (VO2), the volume of CO2 
produced (VCO2), and the ratio between the two (RER). Just before the start of the 20
th 
century, the Atwater-Rosa calorimeter became the first device to simultaneously measure 
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direct and indirect calorimetry. Studies from this chamber verified that indirect 
calorimeter measures in humans were proportional to direct calorimeter measures, and 
were, therefore, an appropriate technique for studying human energetics (7). In the years 
to follow indirect calorimeters became popular research instruments and many 
improvements were made to the devices and techniques used to analyze their data (83). In 
particular, two important equations were developed in the early 1900s that have almost 
ubiquitous use in the field.  
The first is called the Haldane Transform, which was developed by John Haldane 
and Joseph Graham in 1912. This equation allows for the estimation of inspired volume 
(VI) using the measured expired volume (VE) and the concentrations of exchanged gases. 
During indirect calorimetry, gas concentrations are measured as fractions of the total air 
sampled during inspiration (fraction inspired ‘FI’) and expiration (fraction expired ‘FE’). 
The composition of ambient air is typically ~78% nitrogen, ~21% oxygen, and ~.04% 
carbon dioxide (values which are sometimes substituted for direct measurement of 
inspired air). Since gas concentration measurements are fractions they are meaningless 
until multiplied by the absolute volume of air exchanged (i.e., VI and VE). This makes the 
volume measurements very important in the calculations of VO2 and VCO2, as can be 
seen in equations 2 and 3. 
VO2 = VI ∙  FIO2 – VE ∙  FEO2       
 Eq. 1 
VCO2 = VI ∙  FICO2 – VE ∙  FECO2       
 Eq. 2 
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However, VI can be difficult to measure experimentally. For this reason, the Haldane 
Transform can be used to estimate VI, based on the assumption that no nitrogen exchange 
occurs in the lungs (a topic that is outside the scope of this review). The Haldane 
Transform is as follows for the calculation of VO2, but can be used likewise for the 
calculation of VCO2. 
 
As can be seen in Eq. 3, VI has been replaced by VE multiplied by the correction factor 
kH. The correction factor represents the ratio of volume inspired to volume expired. The 
Haldane Transform is widely used in the field of research and has been shown to be an 
accurate means of calculation when used in normal atmospheric conditions (FIO2  21%) 
(65, 83).  
 The second important equation is related to the calculation of energy expenditure. 
This equation was first described by J.B. de V. Weir in his 1949 article in the Journal of 
Physiology (106). It has since come to be known as the Weir formula. One of the 
desirable attributes of indirect calorimetry is that it allows the calculation of metabolic 
rate (energy expended per unit time), both total and by individual substrate contribution. 
Weir had recognized that it was common in metabolic research to calculate energy 
expenditure (in kcals), without either measuring or correcting for protein metabolism. For 
this reason, he set out to demonstrate that protein metabolism could easily be accounted 
for using several simple methods. Previous works had determined the kcals produced per 
liter of O2 consumed in the metabolism of carbohydrate, protein, and fat. Using these 
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Weir developed a formula where protein metabolism could be estimated from urinary 
nitrogen; 
Total kcals = (3.941 ∙  VO2) + (1.106 ∙  VCO2) – (2.17 ∙  grams of urinary nitrogen) 
 Eq. 5 
a formula where protein metabolism could be assigned a constant contribution p; 
Total kcals = ((3.941 ∙  VO2) + (1.106 ∙  VCO2)) / (1 + .082p)   
 Eq. 6 
and a formula where protein metabolism can be ignored with less than .2% error, so long 
as protein contribution is between 10-14%; 
Total kcals = ((3.9 ∙  VO2) + (1.1 ∙  VCO2))      
 Eq. 7 
These equations remain a popular means of calculating energy expenditure today and are 
directly integrated into many indirect calorimetry systems (106). The use of Eq. 7 will be 
appropriate in this study as the conditions are unlikely to induce a large use of protein for 
energy production.  
 Since 1949 numerous studies have been completed using indirect calorimetry. 
Today it may be the most widely used tool in the world of exercise science. Indirect 
calorimetry is a common tool in other fields as well, such as nutrition, pediatric care, and 
animal research. Depending on the purpose of the experiment many different metrics may 
be derived from this one measurement technique. Discussed here are important papers 





 The maximal rate that an individual can consume O2, which is dependent on 
intake, transport, and use, is termed VO2 max. The origins of this measurement lie with 
the observations of Hill and Lupton in 1923 when they described the tendency of O2 
consumption to increase linearly with workload until a certain point where it would 
plateau despite an increase in workload (46).  Consumption of O2 is reliant on the 
pulmonary, cardiovascular, and muscular systems and maximal consumption is, 
therefore, an indicator of the function of these combined systems (34). Specifically, the 
lungs are responsible for bringing O2 into the body, which then needs to be transferred to 
the blood where it is bound to hemoglobin. Once O2 is in the blood, the heart must 
circulate that blood to the working tissue, where the O2 can be transferred again into the 
cells. Finally, the mitochondria in the cells must be able to uptake and use the O2, to 
ensure that a concentration gradient (which drives O2 transfer) is maintained. The test 
itself is usually performed on a cycle ergometer or a treadmill, and the work rate is 
increased gradually until the max is reached. Although it is a subject of debate, VO2 max 
is generally considered to be limited by O2 delivery (SV ∙ HR) and not O2 utilization 
(avO2 diff). Physical activity and exercise training can cause physiological adaptations 
(Fig. 16) that improve VO2 max, which is important as this may decrease mortality risk 




Figure 16. Physiological adaptations that lead to an improvement in VO2 
max. (78)  
 
O2 Deficit 
At the onset of exercise, energy demand increases immediately to a level 
dependent on the activity intensity. The pulmonary, circulatory, and metabolic processes 
required for oxidative energy production cannot increase instantaneously and will slowly 
rise to meet energy demand. The difference between the actual O2 consumption and the 
amount required to meet energy demand is termed O2 deficit (Fig. 17) (40). At low-
moderate exercise intensities, oxidative energy production will eventually meet demand 
and O2 consumption will plateau. During a constant work rate exercise, the level of this 
plateau can be used to estimate the energy demand for the entirety of exercise (red line in 
Fig. 17). While in a state of O2 deficit the non-oxidative pathways (PCr and glycolysis) 
provide the remainder of energy needed. This has led various researchers to suggest that 
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measures of O2 deficit could be used to estimate an individual’s “anaerobic capacity” (8, 
79). Deficit increases linearly with exercise intensity, meaning there is greater non-
oxidative reliance at higher work-rates. Larger O2 deficits are associated with lower 
exercise tolerance and earlier onset of fatigue (29). Exercise training, however, can 
reduce the O2 deficit for a given workload and potentially increase exercise tolerance 
(84). Physiological adaptations that lead to a decreased O2 deficit are identical to those 
that improve VO2 max, including those affecting O2 delivery (i.e., cardiovascular 
adaptations) and utilization (i.e., increased mitochondrial size and content, etc) (90). 
 
Figure 17. Oxygen consumption in response to exercise over time. Adapted 
from (62).  
 
Excess Post-Exercise Oxygen Consumption 
After the cessation of exercise, oxygen consumption remains elevated above 
resting levels despite the apparent immediate decrease in energy demand (Fig. 17). This 
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is termed excess post-exercise oxygen consumption (EPOC), and its magnitude is 
proportional to both the duration and intensity of the exercise (40). Post-exercise oxygen 
consumption follows an exponential curve as it recovers to baseline resting values. This 
recovery curve can be broken into two components: an initial rapid decrease in O2 
consumption (fast component) and a prolonged gradual decline in O2 consumption (slow 
component) (Fig. 18). The excess O2 consumed during the fast component is believed to 
contribute to the replenishment of hemoglobin and myoglobin oxygen stores (within 
seconds) and the oxidative regeneration of PCr to resting levels (within minutes). The 
excess O2 consumed during the slow component is believed to be due to the residual 
elevation in ventilation and heart rate, lactate’s oxidation or conversion to glucose, 
glycogen synthesis, an increased rate of metabolism due to elevated temperature and 
catecholamine levels, re-establishment of ionic equilibrium, and potentially an increased 
protein turnover (38, 40). The total duration of EPOC can be anywhere from a few 
minutes to multiple hours. A study by Knab and colleagues showed an elevated metabolic 
rate as long as 14 hr in response to a 45 min cycling bout (60). In a study examining the 
effect of training status, trained participants were shown to have EPOCs that were shorter 
in duration but similar in magnitude (area under the curve) when compared to untrained 
participants exercising at the same relative intensity. This study also suggested the 
cardiovascular and muscular adaptations that occur with exercise training and affect 
oxygen delivery and utilization were responsible for the faster recovery rates due to an 
increased efficiency of metabolic regulation (100). These adaptations, again, are the same 




Figure 18. Visualization of EPOC fast component (Phase 1) and 
slow component (Phase 2). (38) 
 
Substrate Use 
 The amount of carbohydrate, fat, or protein oxidized is termed substrate use 
(because protein oxidation is minimal in most cases it will be ignored here). 
Carbohydrates and fat are each oxidized in tissue with a unique ratio of CO2 consumption 
to O2 production, which is called the respiratory quotient (RQ) (Fig. 14). The ratio of O2 
production and CO2 consumption of an entire cell is, therefore, the average of the RQ for 
all of the substrates oxidized, and can be used to determine the relative proportion of 
substrate use. Because the O2 and CO2 exchange at the cells is mirrored at the lungs, 
pulmonary gas exchange can be used to estimate RQ (Fig. 19a). This is done through the 
measurement of the ratio of VCO2 to VO2, or the respiratory exchange ratio (RER), and 
is representative of the substrate use for the whole-body. The value of RER generally 
ranges from ~.7 to ~1, and each increment is associated with a percentage contribution 
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from carbohydrate and fat (Fig. 19b). Different calculations based on the setting in which 
RER is measured (rest vs exercise), can then be used to determine the absolute amount of 
substrate oxidized (51). The use of RER has been validated through a carbon isotope 
exchange technique, and was shown to be a valid measure at steady-state intensities up to 
75% of VO2 max, but not valid during higher intensities or work-to-rest transitions (51).   
 
Figure 19. a.) Gas exchange at the cells and lungs; b.) Caloric values of O2 and 
CO2 for non-protein RQ and proportions of substrate used  (a (90), b (64))  
 
Substrate use at a given intensity is variable across the population but is relatively 
invariant in an individual (51). One way to characterize substrate use in an individual is 
to find their crossover point, which is the intensity at which carbohydrate oxidation 
exceeds fat oxidation (Fig. 20). Training has been shown to increase fat use across 





Figure 20. Crossover point and the effect of training. Adapted from (13). 
 
Measurement Comparison 
 As stated at the start of this review, the goal of this thesis is to provide strong 
evidence of the relationship between measured characteristics at the muscle and the 
whole-body level. Now that the measures have been described it is important to note the 
similarities and differences between the two methods. This is perhaps most efficiently 
done through the use of a table (Table 1).  
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Table 1. Comparison of 31P-MRS and Indirect Calorimetry Measures 
 
It is also important to note that because both levels measure characteristics of 
energy expenditure and reflect the acute energy demands placed on the body, they will 
likely be affected similarly by physiological adaptations brought on by chronic energy 
demand. For instance, during prolonged walking or running, energy demand will increase 
and stress both the muscles involved (such as the VL) and other systems in the body 
(such as the cardiovascular system). Stress which over time leads to adaptation. This 
notion will be expanded upon in the next section, which reviews the literature directly 
related to this project. 
Problem to be addressed and proposed solution 
Problem to be Addressed 
Aging and physical inactivity leads to a decline in mobility-related function, 
which includes a decrease in walking speed, postural control, and the ability to transition 
from sitting to standing or walking (30, 35). Mobility limitations are associated with 
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increased falls and healthcare use and expenditures, and a decreased quality of life in 
older populations (27, 35, 85). Performance of mobility test such as the ‘timed up and go’ 
can predict all-cause mortality (12). Aging and physical inactivity are also associated 
with a decline in muscle oxidative capacity, specifically in the knee extensor muscles, 
which is likely detrimental to mobility-related function (Fig. 21) (2, 23, 24, 30, 36, 97, 
108). However, even modest improvements in mobility-related function have been 
suggested to increase physical, emotional, and social well-being in older adults (12, 95). 
For these reasons, our lab has long researched age and physical activity-related changes 
in muscle energetics, to support the combat of age-related declines in mobility and 
physical activity (18, 36, 66, 96, 105). 
 
Figure 21. The mechanistic pathway connecting aging, muscle energetics, 
mobility, and health outcomes. (* indicates the relationship of interest here). 
Adapted from (24). 
 
As discussed above, the vital role and large energy requirements of muscle during 




Correspondingly, researchers have sought to determine the effect of decreased energetic 
function on mobility performance (23, 24, 97, 108). In 2013, Coen et al. (24) were the 
first to investigate the association between of three different oxidative energy measures 
(in vitro mitochondrial respiratory capacity, in vivo muscle oxidative capacity, and VO2 
peak) on preferred walking speed over 400 in older adults. They found that all three 
energetic measures were significantly associated with preferred walking speed, such that 
individuals with a lower energetic capacity tended to walk slower. Similarly, in 2016 
Choi et al. (23) found that muscle oxidative capacity was positively associated with 
preferred walking speed during a 1.5 min test, as well as maximal walking speed over 6 
and 400 m, but not preferred walking speed over 6 m. This led them to suggest that 
muscle bioenergetics may be a limiting factor for walking performance in tasks of greater 
duration and intensity (23). Given the duration of a 6 m walk (< 20 s) it would seem 
unlikely that muscle energetics would be a limiting factor in the absence of serious 
impairment. Santanasto et al. demonstrated a positive relationship between muscle 
oxidative capacity and walking speed as well, although the association fell apart for older 
adults with lower physical function (mean SPPB = 7.8 ± 1.2) (97). In cases of impaired 
physical function, other comorbidities such as muscle weakness, neurological disease, or 
previous injury may have a larger impact than decrement in energetic function. In an 
attempt to identify the mechanism by which muscle oxidative capacity affects walking, 
Zane et al. (108) found that this interaction is partially mediated by muscle strength for 
short-duration activities but not for long-duration activities. This finding suggests that 
although during short-duration activities the effect of decreased muscle oxidative 
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capacity may be confounded by decreases in muscle strength, the same does not appear to 
be true for long-duration activities. 
While the above studies provide robust evidence of the relationship between 
muscle energetics and mobility in a large sample of older adults (total n=551), they are 
largely limited to the measurement of one in vivo energetic variable and a relatively low 
number of mobility outcomes. Also, the mechanism by which muscle energetics impacts 
mobility remains unclear, and it seems likely that other characteristics of muscle 
energetics, such as non-oxidative ATP flux, may be of importance as well. A more 
comprehensive framework of the relationship between muscle energetics and mobility-
related function, such as the one proposed in Fig. 22, would be beneficial for 
understanding and combating aging and physical inactivity-related issues. One major 
obstacle to this is the restriction of 31P-MRS measurement to the bore of a magnetic 
resonance scanner. If in vivo muscle energetics could be assessed during mobility tasks, it 
would be much easier to uncover a potential energetic mechanism by which performance 
in those task may be impaired. While technology is far from allowing this type of 
analysis, measurement of whole-body energetics may provide an alternative mechanistic 
avenue. Although a correlation between muscle and whole-body energetic characteristics 
cannot prove causality, it would show that the changes in whole-body energetics (that 
have been associated with decreases mobility-related function), can be partially explained 
through decrement in muscle energetic function. Such a relationship would suggest that 
improving muscle energetic capacity - perhaps through isolated single joint exercises - 




Figure 22. The proposed framework for physiological interactions that lead 
to decreases in mobility-related function. Adapted from (24). 
 
Proposed Solution 
Characteristics of whole-body energetics have long been linked to exercise 
performance (26, 52, 104), and more recently measures of mobility-related function (4, 9, 
15, 98, 99). Indirect calorimetry measurements of whole-body energetics have also been 
linked to those of in vivo muscle energetics (2, 63, 111) and their relationship has even 
been evaluated simultaneously on multiple occasions (19, 21, 73, 82, 93, 94), albeit only 
in highly constrained settings. Based on these observations whole-body energetics could 
potentially act as an intermediary point between muscle energetics and mobility-related 
function (Fig. 22). 
 
The Advantages of Whole-body Energetic Measures 
 Due to its relatively low cost and accessibility, non-invasive nature, and 
physiological relevance, indirect calorimetry has become a popular means of bioenergetic 
study. Indirect calorimetry measures have long been performed on athletes where they 
have been used as indices of performance or fitness (33), or a tool for training (101). 
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These approaches have also been applied in the world of medicine in the areas of diabetes 
(13), cardiorespiratory fitness (75), pediatric care (83), nutrition (45), and aging (61, 80, 
88). From such studies we know that in older adults the energy cost of daily activities and 
exercise are relatively higher (61, 107), exercise capacity is lower (107), and VO2 
recovery kinetics are slowed (88). 
 Recently, a growing number of studies have used indirect calorimetry to evaluate 
the effects of aging components of mobility-related function. Many of these studies have 
focused on the impact of the increased energetic cost of walking and decreased aerobic 
capacity (VO2 max) observed in older adults (9, 92, 98, 99). Their findings suggest that 
the slowing of gait speed that occurs with walking may be a compensatory action for the 
increased energetic cost, such that older adults walk slower to maintain an energy 
expenditure during transport similar to that of young healthy individuals  (9, 92, 98, 99). 
An increased energetic cost of walking has also been shown to be associated with higher 
rates of perceived fatigability and rating of perceived exertion cross-sectionally (9, 92), 
and more recently longitudinally (98). It has also been proposed that the difference 
between walking oxygen consumption and maximal oxygen consumption, representing 
the “aerobic reserve”, has important consequences for mobility, such that older adults that 
with a smaller aerobic reserve may be more limited during mobility task. Likewise, older 
adults that require a higher percentage of their peak oxygen consumption to walk have 
been shown to have reduced preferred gait speed and increased fatigability (92, 98). 
Other metrics, such as the kinetics of O2 uptake have received less attention, but 
may be equally as important. In 2003, Alexander et al. (4) suggested that, although 
aerobic capacity is often used as an indicator of function in older adults that submaximal 
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measures (O2 kinetics) may be a more practical measure of aerobic function because it 
does not require maximal effort testing; which can be confounded by participant 
motivation or other pathological limitations. In testing this, it was shown that when 
compared to unimpaired older adults (VO2 peak >18 ml∙kg
-1∙min-1), impaired older adults 
(VO2 peak <18 ml∙kg
-1∙min-1) had over twice the time constant for O2 deficit and trended 
towards (p=.09) a 43% higher time constant for EPOC (Fig. 23 A-B.). It was also 
demonstrated that O2 kinetics were as strong or stronger predictors of functional 
performance during a variety of mobility-related tasks (Fig. 23 C.) (4), and low-




Figure 23. A-B) Oxygen deficit and EPOC in 
unimpaired and impaired older women, respectively, 
C) Pearson’s correlations between aerobic 
measurements and mobility test performance. (4) 
 
A limitation of all of these studies has been the measurement of aerobic metrics 
during brief periods of walking or running in a laboratory setting. For example, 
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Alexander et al. measured O2 kinetics in response to a very slow (1 mph) 6 min treadmill 
walk, with only 3 min of collection pre and post, and the other studies measured only the 
total cost of walking and VO2 peak or max. Although walking is a major component of 
mobility, the whole-body energetic responses during the mobility task themselves could 
be beneficial for assessing mobility-related functions during daily living. Also, longer 
periods of measurement may be useful as metrics such as EPOC have been shown to last 
as long as 14 hr in response to more intense exercise. In 2013, Buchowski et al. (15) 
measured energy expenditure in response to eight different physical tasks, for three hours 
in a whole room calorimeter. This was one of few studies to examine the effects of 
energy expenditure during a task on perceived fatigability and performance fatigability 
(measured through accelerometry), and they found both were significantly related to total 
energy expenditure during the task that required around 3.5 METs (15). However, they 
only considered the amplitude of energy expenditure, and based on Alexander’s research 
it is possible that further analysis of O2 kinetic measurements may have uncovered 
associations between energetics and fatigability during lower-intensity tasks as well. This 
is an approach that our lab could potentially use in the future. 
Together these studies demonstrate the efficacy of indirect calorimetric 
measurements for the assessment of mobility-related function. It should be clear that 
linking these lines of energetic research to in vivo muscle energetic research could be 
greatly beneficial to both sides and may provide a mechanistic pathway by which altered 
muscle energetics impact mobility-related function. As will be explained in the following 
section, much of the groundwork to establish this connection has already been completed. 
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While inferences based on this work could currently be made, it is the aim of this study to 
validate these assumptions.  
The Relationship between Muscle and Whole-body Energetics 
 Basic physiology and logic dictate that muscle energetics are related to whole-
body energetics as follows; 1) indirect calorimetry measures the sum of energy 
expenditure (O2 consumption and CO2 production) from all of the body’s cells, 2) muscle 
accounts for ~20-30% of whole-body energy expenditure during rest, and up to ~90% 
during exercise depending on intensity (110), 3) the way muscles use energy (muscle 
energetics) should, therefore, have an impact on whole-body energetics with an 
amplitude corresponding to the activity being performed. The precise interactions of this 
relationship, however, are not implicit and have thus been subject to investigation. 
Chilibeck et al. in 1998 and Rossiter et al. in 2002 (21, 93), both approached this problem 
by simultaneous measurement of phosphorous and O2 kinetics (i.e., rates of change). 
Both groups used isolated exercise (plantar flexion and knee extension) inside a magnetic 
resonance scanner and found similar time constants and kinetics between measurements. 
Rossiter et al. also found that during intense exercise the VO2 slow component was 
reflected in PCr consumption (Fig. 24). Other research groups have used this connection 
to investigate topics such as energy cost, energy efficiency, and quantification of aerobic 





Figure 24. The simultaneous response of VO2 and PCr kinetics to 
different intensity constant rate exercise. The graphs on the left are from 
the onset of exercise and the graphs on the right are from the cessation. Filled 
circles represent heavy exercise and open circles represent moderate (93). 
 
 These studies are limited to exercise in the confines of a magnetic resonance 
scanner. Thus, other researchers have used non-simultaneous measures to investigate the 
importance of muscle energetics in relation to more practical whole-body measures. For 
example, Zwaard et al. (111), showed that although VO2 max is likely limited by O2 
delivery and not mitochondrial respiration, that muscle fiber oxidative capacity (in vitro) 
is highly correlated (r2 = .81-.89) with VO2 max in diseased (CHF), healthy, and 
endurance-trained participants. Similar observations found that muscle mitochondrial 
capacity in the gastrocnemius assessed by near-infrared spectroscopy was associated with 
VO2 peak (R
2 = .57) and EPOC duration (R2 = .34) (63), and that age-related decline in 
muscle oxidative capacity in the vastus lateralis measured by 31P-MRS correlated with a 
decline in VO2 peak (R
2 = .541) as well (3).  
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While these measures add a level of practicality to interpreting the whole-body 
effects of alterations in muscle energetics, they do not provide enough support for the 
comprehensive analysis of how such alterations might affect mobility-related function in 
everyday life that is the goal of this lab. For this reason, this study attempted to elucidate 
a strong relationship, if one exists, between dynamic measures of both muscle and whole-
body energetic characteristics. 
Summary  
 In summary, 1) the methods used to evaluate muscle energetics and whole-body 
energetics are valid and have strong physiological bases; 2) there is reason to believe that 
characteristics of both are inherently connected, especially in regards to exercise; 3) 
characteristics observed at both levels have been previously associated with indices of 
mobility-related function, but more thoroughly and directly at the whole-body level; 4) 
analysis of kinetic attributes at both muscle and whole-body levels and not just total or 
maximal energy consumption could further the understanding of this connection, as well 
as the relationship to mobility-related function; and 5) whole-body energetics could 
potentially act as an intermediary point between muscle energetics and mobility-related 
function, which with further research could advance the field by providing a mechanism 








 This thesis study was completed on a subset of data from a larger multi-lab 
project. As such, portions of the larger project that are not directly relevant to this thesis 
are not included here but can be provided upon request. The purpose of this project was 
to evaluate the connection between muscle (vastus lateralis) and whole-body energetics. 
Muscle energetics were analyzed using MRS in response to two separate knee-extensor 
contraction protocols and whole-body energetics were analyzed using indirect 
calorimetry in response to a treadmill walk designed to mimic what an individual might 
encounter during a typical day. 
All participants completed 4 total visits at the Institute for Applied Life Sciences 
inside either the Center for Human Health and Performance (CH2P) or the Human 
Magnetic Resonance Center (hMRC). The first visit included consenting (informed 
consent can be found in Appendix A), anthropometric measures, a dual-energy X-ray 
absorptiometry (DXA) scan, and a 30-min treadmill walk (30MTW) monitored by a 
metabolic cart. The following three visits consisted of two stays in a whole-room 
calorimeter (24-h visits), and one 3-h visit (MR Visit). The 24-h visits consisted of an 
overnight stay including three meals, structured activities of daily living (ADL’s), and the 
30MTW, all interspersed with free-time. The MR visit included magnetic resonance 
spectroscopy (MRS) measures, both at rest and during knee extension exercise, followed 
by a graded maximal oxygen consumption treadmill test (VO2 peak test). For all visits, 
participants were asked to abstain from alcohol, tobacco, and exercise for the previous 24 
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hours, and caffeine the morning of. All visits were completed within 30 days. An 
overview of the visits and measurements is shown in Fig. 25. 
 
 
Figure 25. Study Visit Overview. DXA, dual-x-ray absorptiometry; 30MTW, 
30-min treadmill walk; RC, room calorimeter; MR, magnetic resonance; MRS, 
magnetic resonance spectroscopy; VO2, volume of oxygen consumed. 
 
Participants 
 This study has been approved by the University of Massachusetts Amherst 
institutional review board. Eight young (25-40 yrs.), healthy males were recruited for this 
study. All participants were relatively weight stable (∆ weight < ± 5lbs for two months 
prior) and ranged from sedentary to recreationally active. Participants were free of any 
musculoskeletal injury, and acute or chronic illness that may affect their neuromuscular 
or metabolic function. Additionally, participants were screened for medications that have 
the potential to impact study results (screening form can be found in Appendix B). 
Dietary restrictions and preferences were also be recorded to ensure the safety of and 




 For all visits, participants were fed a standardized 400 kcal meal bar (PRO Bar, 
Park City, UT) at 11:30 am for lunch (for the MR visit the bar was given to the 
participant prior). The macronutrient distribution was 43g of carbohydrate, 22g of fat, 
and 11g of protein, and was chosen to be both satiating and relatively low calorie. The 
key measurements of each visit (indirect calorimetry and MRS) occured roughly 2.5-3.5 
hrs after lunch (commencing at ~2:00 pm). This standard meal and timing helped to 
control for the thermic effect of food on energy expenditure as well as other meal-based 
stimuli and diurnal variations, however, some inter-participant variation likely remained. 
Descriptive Data 
Physical Activity Monitoring 
 Following Visit 1, participants were asked to wear a GT3x+ accelerometer 
(ActiGraph, Pensacola, FL) on their dominant hip for 7 days, and fill out an 
accompanying physical activity log to classify their habitual, free-living physical activity. 
This is a standard practice in our lab, and these data were used to identify free-living 
physical activity levels and determine their potential effect on the results. The participant 
was instructed to wear the accelerometer on their right hip. A minimum of 4 days with 10 
hours of wear time per day was required to be included in the analysis. ActiLife v6.13 
software (ActiGraph, Pensacola, FL) was used to calculate average daily activity counts 
as well as minutes spent in moderate-to-vigorous physical activity. 
During each 24-hour visit participants tracked their step count using the screen on 
a GT9X accelerometer (ActiGraph, Pensacola, FL) and were asked to reach a step count 
goal of 1200 steps before 12:00 pm in an attempt to avoid complete inactivity. 
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Anthropometrics and DXA Scan 
 Height, weight, and femur length (greater trochanter to lateral condyle) were 
measured and recorded for all participants. All measures were completed twice and 
averaged. Next, a full-body DXA scan was obtained by a certified technician on a Lunar 
iDXA (GE Lunar, Madison, Wisconsin, USA), to quantify body composition. These data 
were used for normalization and anthropometric comparison of participants, as well as 
for choosing the correct height settings on the magnet ergometer. Primary outcomes of 
these measurements included weight, body mass index (BMI), lean body mass (LBM), 
and fat mass. 
Whole-body Metabolic Measures 
Treadmill Walk 
 The 30MTW protocol (37, 43) was performed at 2:00 pm during visit 1, and both 
24-h visits. The treadmill speed (incline = 0%) was increased over the first 30 s until 1.3 
m∙s-1 is reached. This speed was set to be achievable by most populations and was based 
on the average overground walking speed (1.37 m∙s-1) completed by 17 older women in a 
previous study in our lab (37). At minutes 7, 17, and 27, grade was increased to 3% for 1 
min to provide a slight challenge and to simulate a hill that the participant might 
encounter in everyday life. After 1 min, the grade was returned to level. Immediately 
before the 30MTW, participant gas exchange rates was measured during 20 min of quiet 
sitting followed by 10 min of quiet standing during which time a television show was 
played. Following the walk, the participant were required to remain seated and passive 
for a 1-hr recovery period at visit 1 and a 2-hr recovery period at the 24-h visits, during 
which time a television show was played.  
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During the first visit, metabolic response to the 30MTW were monitored with a 
Parvo Medics’ TrueOne® 2400 (Salt Lake City, UT) metabolic cart, which was 
calibrated according to manufacturer recommendations prior to the participant’s arrival. 
Data was sampled breath by breath and recorded in ~5-s averages. During post-
processing, data was inspected for errors and smoothed using a 3-sample (~15 s) centered 
moving average.   
During the 24-h visits, metabolic response to the 30MTW was monitored using a 
custom-built full room calorimeter (MEI Research, Enida, MN) as part of a longer 24 hr 
stay. The calorimeter (4.1 by 3.3 m) is configured for long-duration stays during which 
individuals can receive meals or medications through pass-through ports. It houses a 
toilet, sink, bed, desk, TV, treadmill (Valliant 2, Lode, Groningen Netherlands), and a 
two-camera observational video system. The calorimeter was calibrated using zero (0% 
CO2, 21% O2) and span (1% CO2 and 20% O2) gases before the participants arrive. A 
walkie-talkie was provided for communication while inside the calorimeter. Data was 
sampled every 15s and post-processed using a 6-min centered derivative.   
These data were used to determine the energetic response to and recovery from a 
light intensity free-living task. Data from the first visit allowed for oxygen kinetic 
analyses of higher temporal resolution than can be recorded from the room calorimeter. 
Data from the 24-h visits allowed for analysis of a longer recovery period than would be 
comfortable with the metabolic cart.  
VO2 Peak Measures.  
Following the MR measures, the participant was removed from the scanner and 
given time to use the restroom, then was taken upstairs to the CH2P for measurement of 
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peak oxygen consumption (VO2 peak). Graded exercise tests have long been used to 
determine the maximal amount of oxygen that can be consumed for aerobic (oxidative) 
energy production, often referred to as VO2 max. In this study, we chose to use the term 
VO2 peak as opposed to VO2 max due to the inherent difficulties in determining whether 
or not an individual truly reaches their physiological limit. Our use of the term peak 
denotes that we accept that our values may not represent true maximal values, but simply 
the peak values observed on that day. Participants completed a self-paced ~5-min warm-
up on a treadmill. A TrueOne® 2400 metabolic cart was used to measure gas exchange 
and respiration rate during the VO2 peak test. Data was sampled breath by breath and 
recorded in ~5-s averages. The test followed the BSU/Bruce Ramp treadmill protocol as 
described by Kaminsky and Whaley (53). This protocol is designed to be well suited for a 
wide range of populations through its use of a gradual ramp in intensity allowing for long 
walking periods and small transitions between stages. The test begins with a .76 m∙s-1 flat 
walk and gradually increases in speed or incline. Heart rate, oxygen consumption, and 
RPE were monitored throughout the test. Termination criteria consisted of any one of the 
following, volitional fatigue, a plateau in oxygen uptake at several consecutive 
workloads, safety concerns, or equipment malfunction. During post-processing, data was 
inspected for errors and smoothed using a 6-sample (~30 s) centered moving average. 
The highest 30 s average was taken as the VO2 peak, which was the primary outcome of 
this measurement. A table detailing the test stages can be found in Appendix C.  
Muscle Bioenergetics 
Magnetic Resonance Measures 
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 Upon arriving at the hMRC, participants reviewed the MR Safety Form with the 
MR Technician, and all metal objects were removed. They were escorted into the scanner 
room and positioned on their back on the bed of the 3 Tesla whole-body MR system 
(Siemens, Erlangen, Germany). Their dominant leg was be strapped into the custom-built 
leg exercise apparatus, which is similar to a knee extension machine one might use at a 
gym. The leg was strapped to the apparatus just above the ankle and above the knee using 
Velcro straps. Inelastic straps were secured over the participant’s hips to prevent 
unwanted movement during the muscle contractions. A circular 10-cm, dual-tuned 
(phosphorus and proton) coil was secured over the belly of the vastus lateralis muscle 
using an elastic bandage and Velcro straps. After the participants were secured to the leg-
exercise apparatus, their thigh was positioned in the isocenter of the scanner and the 
magnet was shimmed. After the magnet was shimmed to an acceptable level of 
homogeneity, resting proton spectra was obtained for the measurement of cytosolic 
acetyl-carnitine. These measurements will be used in the analysis of the muscle energetic 
response to exercise in a tangential study. A visual outline of the magnetic resonance 
procedures can be seen in Fig. 26. 
 
Muscle Power Measures 
Figure 26: Magnetic Resonance Spectroscopy Protocol 
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 Participants completed 2 practice submaximal isometric contractions, followed by 3 
maximal voluntary isometric contractions (MVIC), each lasting 3-4 s, to establish the 
workload for the ramp contraction protocol. One minute of rest was given between each 
set of contractions. Participants were then be familiarized with isokinetic contractions (1 
contraction every 2 s at 120 s-1) by performing 2 sets of 3 contractions. During all knee 
extensor protocols, participants had visual feedback showing the torque they produced as 
well as their target torque and the timing of contractions.  
Oxidative Capacity 
 The oxidative capacity protocol consisted of 90 s of rest, 24 s of maximal 
isokinetic contractions (1 contraction every 2 s at 120 s-1), and 10 minutes of recovery. 
Phosphorus spectra was collected at 2 s resolution for the entire protocol. During post-
processing, the first 15 spectra (30 s) were discarded to avoid saturation issues. The 
remaining resting spectra were then averaged together into one 60 s spectrum. During the 
24 s of exercise and the first 20 s of recovery spectra were averaged to 4-s resolution, the 
following 280 s of recovery to 8-s, and the last 300 s to 30-s. These data were used to 
determine the maximal aerobic energy production in the muscle. The primary outcome 
for this measurement was muscle oxidative capacity (measured as a rate constant, kPCr, s
-
1). 
Ramp Contraction Protocol 
Following the oxidative capacity measures, participants performed a ramp 
contraction protocol consisting of 90 s of rest, four 2-min stages of isotonic knee 
extensions (1 contraction performed every 2 s), and 10 min of recovery. Resistance for 
the stages were set at 6, 9, 12, and 15% of MVIC and occured in that order. Phosphorus 
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spectra were collected at 2 s resolution for the first 12 min of the protocol. Two and a half 
minutes into recovery, phosphorus scans ceased and ~5.5 min of proton shimming and 
scanning was performed (for purposes outside the scope of this project), following which 
two and a half more minutes of phosphorus were collect at 2 s resolution. In this way, we 
collected a full ~10 min of phosphorus recovery, with a gap in the middle that can be 
accounted for through a monoexponential fit. During post-processing, the first 15 spectra 
(30 s) were discarded to avoid saturation issues. The remaining resting spectra were then 
averaged together into one 60 s spectrum. During the 480 s of exercise spectra were 
averaged to 10-s resolution, the first 20 s of recovery to 4-s, the following 128 s to 8-s, 
and the last 150 s collected after the proton scanning to 30-s with the first 15 spectra 
discarded. These data were used to evaluate the energetic characteristics of contracting 
muscle at various intensities. Primary outcomes included the amplitude of ∆PCr from the 
first intensity stage (PCr mM).  
Kinetic Analysis 
Kinetic analysis of both oxygen consumption and PCr responses was performed 
using the MATLAB 2020a curve fitting toolbox (The MathWorks Inc., Natick, 
Massachusetts). Oxygen deficit was fit from the onset of the 30MTW to just before the 
first challenge period at 7 min using the following monoexponential equation. 
 VO2(t) = (mean VO2 Last Minute of Standing) + a ∙ (1 - e
 (-(t-d)/tc)) 
Eq. 8 
The EPOC was fit from the time the participant has sat down at the end of the 
30MTW through 1 hour of recovery using this similar monoexponential equation. 





The variable a represents the amplitude of change in oxygen consumption, t represents 
time, d represents the time delay between the change in physical work and the oxygen 
response, and tc is the time constant representing the amount of time in seconds it takes 
for the amplitude to change by 63%. All variables were constrained to a minimum value 
of 0.  
The PCr recovery data was fit from the end of the 24-s oxidative capacity protocol 
to 10 minutes of recovery using the following monoexponential equation. 
 PCr(t) = Y0 + a ∙ (1- e (-k ∙ t))  
Eq. 10 
The variable Y0 is the estimated PCr concentration during the last 4 s of exercise, a 
represents the amplitude of change in PCr, t represents time, and k is the rate constant. 
All variables were constrained to a minimum value of 0. 
The PCr data from the first stage of the ramp was fit from the onset of 
contractions to the beginning of the second stage (2 min) using the same equation, except 
the variable Y0 is now the estimated PCr concentration at rest and is subtracted from. 
 PCr(t) = Y0 - a ∙ (1- e (-k ∙ t))  
Eq. 11 
Statistics 
Data was analyzed as a single group. Descriptive data is reported as mean values 
with standard deviation and ranges. Due to the low number of participants correlations 
were assessed with the non-parametric Spearman’s rank correlation coefficient test (rs) in 
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MATLAB 2020a (The MathWorks Inc., Natick, Massachusetts) using the “corrplot” 
function.   
Aim 1: Evaluate the relationships between ∆PCr in muscle and the O2 deficit 
during the 30MTW.  
 
To test Aim 1, a Spearman’s rank correlation test was performed to determine the 
association between the independent variable (∆PCr in the VL during the knee extensor 
contraction protocol; amplitude (a) mM) and the dependent variable (O2 deficit from the 
30MTW, kdeficit). 
Aim 2: Evaluate the relationships between muscle oxidative capacity and: EPOC 
and RER in response to activities of daily living, and VO2 peak from a graded exercise 
test.  
 
To test Aim 2, several Spearman’s rank correlation tests were performed to 
determine the association between the independent variable (muscle oxidative capacity 
from the isokinetic protocol; kPCr, s
-1) and the dependent variables (EPOC and substrate 
use from the 30MTW; kEPOC and RER, and VO2 peak relative to total and lean body mass 








Male participants aged 25-40 years who were not actively training for or 
participating in organized sports were recruited for this study. Eight participants were 
enrolled and completed all four visits. Upon enrollment, each participant was assigned an 
arbitrary number between 1 and 11 to serve as a de-identified participant code (denoted 
here as pt#). All participants self-reported being weight stable (< ±5lbs for 2 months), and 
free from chronic disease and injury. Group data provided in Table 2. 
Table 2. Participant characteristics 
Age (years)   28.4 ± 3.5 (25, 35) 
Height (cm) 179.6 ± 9.3 (164, 189) 
Weight (kg)   88.7 ± 15.5 (65.5, 105.3) 
Lean Body Mass (kg)   64.9 ± 11.6 (47.4, 84.8) 
BMI (kg∙m-2)   27.2 ± 2.7 (22.6, 30.2) 
Body Fat (%)   20.3 ± 7.1 (13.8, 33) 
MVPA (min∙d-1)      33 ± 13.8 (6, 48) 
PA (counts∙d-1000)    400 ± 115 (244, 600) 
MVIC (Nm)    283 ± 67 (172, 370) 
Data are mean ± SD and (range); BMI, body mass index; MVIC, 
maximal voluntary isometric contraction; MVPA, moderate- to vigorous-
intensity physical activity; PA, physical activity 
 
Whole-body Metabolic Responses to 30MTW 
Room Calorimeter Measurements 
Due to the low temporal resolution of the whole-room calorimeter data, a standard 
analysis of oxygen kinetics was not feasible. Further evaluation will be required to 
determine if meaningful kinetic measures can be extracted from these data. For this 




All participants completed the 30MTW protocol at the prescribed speed of 1.3 
m∙s-1. During seated rest (pre and post-walk), all participants watched documentary-style 
television shows. The first 4 participants were allowed ad libitum access to their phones. 
Phone use was not allowed following the 4th participant (pt7) due to unexpected increases 
in VO2 observed while that participant was holding the phone high in front of their face 
for an extended period of time. Additionally, metabolic cart data for one participant (pt4) 
was excluded from analysis due to unusually large oscillations in the VO2 signal that 
made it unsuitable for analysis. It has yet to be determined whether this problem was due 
to an equipment artifact or physiologic phenomenon. 
Metabolic Variables during the 30MTW 
 Analysis of the metabolic cart data from the 30MTW walk protocol showed that 
oxygen consumption increased from sitting to walking by ~3-4 fold for all participants 
and steady-state was reached before the first challenge period 7 min into the walk. 
Oxygen consumption averages from minutes: 10-19 of sitting pre-walk (VO2 Sitting), 5-9 
of standing pre-walk (VO2 Standing), and 7-30 of walking (VO2 Walking) were taken to 
be representative of those periods while avoiding influence from the transitions between 
them. Representative VO2 and RER responses are shown in Fig. 27. Mean treadmill walk 




Figure 27: Representative plot of metabolic data from 30MTW. Data are 
from a single participant (pt9) during the 30-min treadmill walk; VO2, volume 
of oxygen consumption; RER, respiratory exchange ratio. 
 
Table 3. Treadmill walk metabolic variables 






pt1 3.4 3.6 13.7 
pt2 4.3 5.4 12.5 
pt4 - - - 
pt6 3.1 3.5 11.1 
pt7 1.9 2.7 10.2 
pt9 3.7 3.5 10.8 
pt10 3.1 3.3 12.9 
pt11 3.4 3.8 12.9 
Mean ± SD 3.2 ± 0.7 3.7 ± 0.8 12 ± 1.3 
VO2, volume of oxygen consumption 
 
Respiratory Exchange Ratio 
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 The RER response to the 30MTW, was calculated as averages across different 
time periods. Representing RER as an average, as opposed to picking a single time point 
(minimum, maximum, or final), limits the impact of noise in the data. As shown in Fig. 
27, RER during the 30MTW took longer to reach a steady than VO2, a finding consistent 
across participants. For this reason, averages were calculated for the entire oxygen 
consumption steady state (minutes 7-30; RER L23) and the last minute (minute 29-30; 
RER L1) of the 30MTW. Additionally, an average of the last 5 min was calculated 
(minutes 25-30; RER L5), to account for fluctuations that may occur during the last 
minute due to the final challenge period (minute 27-28) or noise that if not sufficiently 
filtered by the small sample of RER L1 (12 data points). The RERs from these three time 
periods (L23, L5 and L1) did not statistically differ by means of one way ANOVA (p= 
0.47) or Kruskal-Wallis test (p = 0.43). Individual RER data can be found in Fig. 28 and 
Table 4. 
 
Figure 28. Individual RER values from the 30MTW. 30MTW, 30-
min treadmill walk; RER, respiratory exchange ratio; L23, average of 
the last 23 min of walk; L5 average of the last 5 min of walk; L1 average 
















Table 4. Individual RER values from the 30MTW 
Participant RER L23 RER L5 RER L1 
pt1 0.89 0.89 0.91 
pt2 0.83 0.84 0.85 
pt4 - - - 
pt6 0.83 0.80 0.83 
pt7 0.86 0.86 0.90 
pt9 0.85 0.84 0.85 
pt10 0.90 0.87 0.89 
pt11 0.87 0.88 0.90 
Mean ± SD 0.86 ± 0.03 0.85 ± 0.03 0.87 ± 0.03 
30MTW, 30-min treadmill walk; RER, respiratory 
exchange ratio; L23, average of the last 23 min of walk; 
L5 average of the last 5 min of walk; L1 average of the last 
1 min of walk; * denotes significantly different means 
 
On- and Off- Kinetics for Metabolic Variables 
To determine the time constants for the oxygen deficit (on-kinetics) and EPOC 
(off-kinetics), monoexponential equations (Eq. 8 and 9) were fit to each participant’s 
oxygen consumption data during the 30MTW. For two participants (pt1 and pt2) the time 
at which the walk ended and the time at which the participants began seated rest was not 
recorded. In these two cases, EPOC was defined as starting from the last VO2 value at or 
above the steady-state mean, and the mean VO2 Last Minute of 30MTW was calculated as 
the average of the minute before that same point. In addition, the minimum time delay (d) 
for these two participants was constrained to -5 s (as opposed to 0) to allow the fit to 
account for a possible error in identifying the end of the 30MTW of up to one data point. 
The fit of the EPOC data for participant 7 was adjusted for the effect of phone use 
mentioned above (see Appendix D for details). Figure 29 shows representative fits of the 
VO2 data illustrating the oxygen deficit and EPOC analyses.  The time constants from 





Figure 29. Representative fits of data showing (A) oxygen deficit and (B) 
EPOC. Data are from a single participant (pt9). Time constants here are 37 s 
for oxygen deficit and 69 s for EPOC. VO2, volume of oxygen consumption. 
 
Figure 30. Individual oxygen deficit and EPOC time constants from 
the 30MTW. EPOC, excess post-exercise oxygen consumption; 
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Table 5. Oxygen deficit variables 
Participant Time constant 
(s) 




pt1 38 (29, 47) 0.78 10.2 1.0 
pt2 25 (5, 45) 0.24 6.7 1.2 
pt4 - - - - - 
pt6 19 (11, 26) 0.37 7.4 0 
pt7 23 (17, 30) 0.67 6.9 0 
pt9 37 (28, 46) 0.64 7.8 0 
pt10 27 (19, 35) 0.61 8.8 0 
pt11 27 (19, 35) 0.70 7.8 1.3 
Mean ± SD 28 ± 7  0.57 ± 0.20 7.9 ± 1.2 0.5 ± 0.6 
SD, standard deviation; 95% CB, 95% confidence bounds for the time constant 
 
Table 6. EPOC variables 
Participant Time constant 
(s) 




pt1 57 (53, 61) 0.63 10.3 -5 
pt2 43 (37, 49) 0.27 8.6 -5 
pt4 -  - -  -  - 
pt6 47 (36, 58) 0.40 7.9  0 
pt7 78 (68, 87) 0.53 8.6  0 
pt9 69 (62, 76) 0.56 7.8  0 
pt10 65 (61, 70) 0.65 9.1  0 
pt11 53  (50, 56)  0.74   9.6   0 
Mean ± SD 59 ± 13  0.54 ± 0.16 8.8 ± 0.9 -1.4 ± 2.4 
EPOC, excess post-exercise oxygen consumption; SD, standard deviation; 95% CB, 95% 
confidence bounds for the time constant 
VO2 Peak 
 The VO2 peak tests ranged from 11 to 16 min in duration, and all tests were 
terminated upon volitional fatigue. For two participants (pt2 and pt6) heart rate data was 
not recorded due to equipment failure. To further evaluate how muscle energetics may 
play a role in this relationship VO2 peak is reported here normalized to both total mass 
(mL∙kg-1∙min-1) and lean mass (mL∙kg lean-1∙min-1).  Representative changes in oxygen 
consumption and RER can be found in Fig. 31. Individual VO2 peak data can be found in 




Figure 31. Representative data from the ramp treadmill protocol. Data 
are from a single participant (pt9). VO2, volume of oxygen consumption; 
RER, respiratory exchange ratio. 
 
 
Figure 32. Individual VO2 peak values from the ramp treadmill 


































Table 7. VO2 peak values from the ramp treadmill protocol 
Participant VO2 Peak 
 (mL∙kg-1∙min-1) 




Max HR Max RPE 
pt1 38.0 52.5 1.34 201 10 
pt2 52.6 72.8 1.10 - 10 
pt4 44.1 59.2 1.23 190 10 
pt6 38.4 60.4 1.14 - 10 
pt7 38.8 51.9 1.27 202 10 
pt9 47.2 61.1 1.22 197 9 
pt10 36.9 51.6 1.25 200 10 
pt11 47.1 57.8 1.20 179 10 
Mean ± SD 42.9 ± 5.7 58.4 ± 7.0 1.20 ± 
0.1 
195 ± 9 9.9 ± 0.4 
VO2, volume of oxygen consumption relative to total mass; Max RER, maximal 
respiratory exchange ratio; Max HR, maximal heart rate; Max RPE, maximal rating 
of perceived exertion; SD, standard deviation. 
 
Muscle Bioenergetic Variables 
Oxidative Capacity 
The 24-s isokinetic protocol led to an average PCr recovery of 14.1 ± 3.8 mM 
(Table 8). No participant’s muscle pH dropped below 6.8 during any part of the protocol, 
suggesting that PCr replenishment was not hindered in any case by H+ accumulation. 
Individual fit variables are shown in Table 8 and a sample PCr fit for a single participant 
can be seen in Fig. 30. 
 
Figure 33: Representative monoexponential fit of PCr recovery data 
from the oxidative capacity protocol. Data are from a single participant 




Figure 34. Individual oxidative capacity rate constants.  
kPCr (s-1), rate constant of PCr recovery; 
 
Table 8. Oxidative capacity individual fit variables 








pt1 0.029 (0.026, 0.032) 0.98 25.0 13.4 
pt2 0.039 (0.035, 0.044) 0.97 20.1 18.7 
pt4 0.023 (0.025, 0.028) 0.99 25.1 14.6 
pt6 0.045 (0.036, 0.054) 0.93 30.2 6.2 
pt7 0.019 (0.017, 0.020) 0.99 25.0 12.9 
pt9 0.034  (0.031, 0.036) 0.99 23.8 16.0 
pt10 0.027 (0.025, 0.030) 0.98 21.4 17.9 
pt11 0.026 (0.024, 0.028) 0.99 24.4 13.3 
Mean ± SD 0.030 ± 0.009  0.98 ± 0.02 24.3 ± 3.0 14.1 ± 3.8 
SD, standard deviation; 95% CB, 95% confidence bounds for the rate constant; kPCr, s-
1, rate constant of PCr recovery. 
 
Non-Oxidative ATP Production 
Data from the first 2-min stage were used to calculate the amplitude of ∆PCr for each 
participant, thereby reflecting the contribution of ATP production from the (non-
oxidative) creatine kinase reaction. The target relative intensity of this stage was 6% of 
MVIC. The mean MVIC was 282 ± 67 Nm and the mean target load was 17 ± 4 Nm. The 

































variables are presented in Table 9 and an example PCr fit for a single participant is shown 
in Fig. 31. 
 
Figure 35. Representative fit of changes in PCr during stage 1 of ramp 

































Table 9. Variables from fit of ∆PCr 








pt1 0.034 (0.027, 0.041) 0.99 38.4 11 
pt2 0.072 (0.037, 0.11) 0.92 37.7 4.7 
pt4 0.017 (0.012, 0.023) 0.99 38.4 10.7 
pt6 0.093 (0.042, 0.14) 0.91 36.4 4.8 
pt7 0.020 (0.016, 0.025) 0.99 38.4 8.6 
pt9 0.021 (0.014, 0.029) 0.97 38.7 7.4 
pt10 0.023 (0.013, 0.032) 0.97 36.9 7.5 
pt11 0.024 (0.017, 0.031) 0.98 36.9 6.9 
Mean ± SD 0.038 ± 0.028  0.97 ± 0.03 37.7 ± 0.9 7.7 ± 2.4 
SD, standard deviation; 95% CB, 95% confidence bounds for the rate constant; kPCr s-1, 
rate constant of PCr depletion. 
Associations between Single Muscle and Whole-body Energetics 
To evaluate these relationships Spearman rank correlation coefficients were 
calculated. The coefficient output rs is similar to the r variable from a Pearson correlation 
and represents the strength of association. A strong Spearman correlation suggest a 
monotonic (directional; up or down) relationship, but not necessarily a linear one. The 
linearity of relationships was inferred through visual interpretation of the association 
plots. Probability values (p-values) were calculated for all correlations as well; however, 
due to the low sample size and this being an exploratory analysis, we did not set an alpha 
level for significance. The magnitude of ∆PCr showed a positive linear relationship with 
oxygen deficit (Fig. 37). Muscle oxidative capacity showed a negative linear relationship 
with EPOC, as shown in (Fig. 38). Muscle oxidative capacity showed a negative linear 
association with the mean RER from the entire steady-state (RER L23), the last 5 min 
(RER L5), and the last minute (RER L1) (Fig. 39). Muscle oxidative capacity had a 
positive linear association with VO2 peak relative to lean mass, but no relationship to 
VO2 peak relative to total mass as shown in (Fig. 40). The correlation coefficients of the 
association between both independent variables and all of the dependent variables 




Figure 37. Association between oxygen deficit and ∆PCr. PCr, 
phosphocreatine; rs, Spearman’s rank correlation coefficient 
 
 
Figure 38. Association between EPOC and muscle oxidative 
capacity. EPOC, excess post-exercise oxygen consumption; PCr, 
phosphocreatine; kPCr s-1, rate constant of PCr recovery; rs, 
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Figure 39. Associations between RER during the 30MTW 
and muscle oxidative capacity. 30MTW, 30-min treadmill 
walk; RER, respiratory exchange ratio; RER L23, average 
RER over the last 23 min of walk; RER L5, average RER 
over the last 5 min of walk; RER L1, average RER of the last 
1 min of walk; PCr, phosphocreatine; kPCr s-1, rate constant 





Figure 40. Association between VO2 Peak normalized to total 
mass and lean mass and oxidative capacity. VO2 peak, oxygen 
consumption; PCr, phosphocreatine; kPCr, s-1, rate constant of PCr 
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Table 10. Spearman’s Rho correlation coefficients 
 ∆PCr Muscle Oxidative Capacity 
Oxygen Deficit (s-1) 0.46 (0.30) -.018 (0.71)  
EPOC (s-1) 0.75 (0.07) -0.64 (0.14) 
RER L23 0.75 (0.07) -0.64 (0.14) 
RER L5 0.71 (0.09) -0.68 (0.11) 
RER L1 0.70 (0.09) -0.74 (0.07) 
VO2 Peak (mL∙kg
-1∙min-1)  -0.52 (0.20)  0.14 (0.75) 
VO2 Peak (mL∙kg
-1 lean∙min-1) -0.62 (0.11)  0.64 (0.10) 
Oxidative Capacity -0.62 (0.11) - 
Data are  rs (p-value), bolded values are from aims; PCr, phosphocreatine; 
EPOC, excess post-exercise oxygen consumption; RER, respiratory exchange 
ratio; RER L23, average RER over the last 23 min of 30MTW; RER L5, 
average RER over the last 5 min of 30MTW; RER L1, average RER of the 






















The purpose of this study was to begin to quantify the links between muscle 
energetics the whole-body energetic response to daily-living type activity (30MTW). The 
aims of this study were to determine whether the oxygen deficit at the beginning of 
whole-body exercise was associated with the rate of muscle non-oxidative ATP at the 
onset of contractions (∆PCr), and whether whole-body EPOC, RER, and VO2 peak were 
associated with muscle oxidative capacity. Our hypotheses were that there would be a 
positive association between muscle ∆PCr and O2 deficit, a negative association between 
muscle oxidative capacity and EPOC as well as RER, and a positive association between 
muscle oxidative capacity and VO2 peak.  
The vastus lateralis muscle was selected for this study because it is a large, 
commonly-studied muscle that plays an important role in ambulation (during which the 
whole-body measurements were taken) as well as mobility-related function (22, 76, 86). 
As no muscle works in isolation, the evaluation of a single muscle is generally completed 
to gain information about a muscle group, the muscular system, or an organism as a 
whole. The question here was: Are the energetic characteristics of a single muscle (vastus 
lateralis) indicative of corresponding characteristics of whole-body energetics? The 
results presented here suggest that they are. 
While attempts were made to maximize the similarity between the muscle and 
whole-body exercises, single-leg knee extension contractions and treadmill walking are 
still fairly disparate activities. We believe this gives more weight to the associations 
presented here, and suggests that the energetic variables described are not just indicators 
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of task performance, but underlying physiological function. The relative similarity of the 
participants- all young (25-35 years) healthy males who were not highly trained- should 
also add weight to the strength of associations, as a study population with a larger spread 
of characteristics would increase the chance that correlations are driven simply by group 
based differences. 
Muscle and Whole-body Non-oxidative Energy Use are Related at the Onset of 
Exercise  
In Aim 1, we explored the relationship between non-oxidative energy use at the 
muscle (∆PCr) and whole-body (oxygen deficit) levels. For whole-body exercise, the 
30MTW was used as it is a light-moderate intensity exercise, similar to what a person 
may perform during free-living walking to the store or going to work. Low-intensity, 
isotonic contractions were selected for the muscle contraction protocol because we 
believed this mode of contraction to be most similar to the type of muscular work 
performed during walking. To approximate the intensity of muscle contractions to those 
occurring during the 30MTW, only the first 2-min stage of the ramp protocol was used in 
the calculation of ∆PCr. It should be noted, however, that while the speed of the 30MTW 
was the same for all participants (1.3 m∙s-1), the intensity of the first stage of the ramp 
was set relative to each individual’s maximal force output (6% MVIC).  
The magnitude of ∆PCr was associated with oxygen deficit (rs = 0.46). This result 
suggests that individuals who were more reliant on PCr (a non-oxidative energy source) 
at the onset of knee extensor contractions were also more reliant on non-oxidative energy 
sources (PCr and glycolysis) at the beginning of whole-body exercise, such as walking. It 
is not clear whether greater non-oxidative reliance is due to an enhanced ability to 
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produce energy non-oxidatively, or a limited ability to rapidly increase oxidative energy 
production. In support of the former, studies have shown that blocking PCr breakdown 
and glycolysis in different preparations of isolated muscle leads to faster oxygen uptake 
kinetics (41, 42, 44, 59). Additionally, the speeding of uptake kinetics (i.e., the shortening 
of oxygen deficit) that occurs with training has been shown to precede changes in muscle 
oxidative capacity measured by citrate synthase activity (89). However, the latter is 
supported in this study by the negative association observed between ∆PCr and muscle 
oxidative capacity (rs = -0.62), as well as VO2 peak normalized to lean mass (rs = -0.62), 
suggesting that individuals with a greater capacity to increase oxidative energy 
production relied less on PCr. Surprisingly, muscle oxidative capacity was not associated 
with oxygen deficit (rs = -0.18), which in addition to the other research cited here, 
suggest that oxygen deficit is a product of a great number of factors and controls that 
warrants further investigation.   
Although oxygen concentration (PO2) in muscle at rest is much higher than what 
is required for resting oxidative energy production, potentially 50-100 fold, how quickly 
PO2 becomes limiting is unclear and likely dependent on exercise intensity (68). It may 
be the case that during light intensity, whole-body exercise the increase in oxygen uptake 
is affected more by the ability of the body to deliver oxygen and nutrients than by the 
inherent characteristics of the muscle, an idea that is a subject of debate in the field (90). 
The fact that oxidative capacity in the VL is associated with greater reliance on PCr at the 
onset of muscle contractions but not at the onset of walking (oxygen deficit), could also 
be due to lower oxidative capacity in other ambulatory muscles. These complexities may 
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explain why the correlation coefficient for the association between ∆PCr and oxygen 
deficit was lower than other relationship shown here. 
Muscle and Whole-body Oxidative Energy Use are Related  
 The relationship between oxidative energy use at the muscle (oxidative 
capacity) and whole-body levels (EPOC, RER, and VO2 peak) was examined in Aims 
2.1-3. The isokinetic muscle oxidative capacity protocol was selected because it causes a 
significant depletion of PCr without greatly disturbing pH, or blood flow (as maximal 
isometric protocols do), which should help ensure that the post-contraction rate of PCr 
recovery represents the maximal ability of the muscle to generate ATP oxidatively (87). 
Given that muscle cells are responsible for up to 90% of oxygen consumption during 
exercise and 30% during rest, the two levels are inextricably linked (110). Additionally, 
the same physiological factors - mitochondrial content, capillary density, and 
concentration of oxidative enzymes - are major determinants for both the independent 
and dependent variables (13, 31, 90, 100). Still, the relevance of a single muscle’s 
oxidative capacity to whole-body energetics is not evident enough that it may be 
assumed. The correlations presented here shed light on the strength and direction of these 
relationships. 
Muscle Oxidative Capacity is Associated with EPOC 
Muscle oxidative capacity was associated with the time constant of EPOC (rs = -
0.64), suggesting that individuals who have a higher maximal rate of muscle oxidative 
energy production may return to resting VO2 levels more rapidly following exercise. The 
time constant for EPOC represents the time it takes for oxygen consumption to recover 
by 63% following exercise, and reflects of the body’s ability to return to homeostasis. 
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Metabolic recovery after exercise is dependent on restoration of metabolite 
concentrations to resting levels, and re-synthesis of PCr makes up a substantial portion of 
EPOC (38). It is then reasonable to expect that the ability to replenish PCr quickly (via a 
high oxidative capacity) would lead to a faster recovery (a lower EPOC time constant). 
However, this would imply that either muscles work at or near their oxidative capacity 
during recovery from low-intensity work, or that a lower oxidative capacity is related to 
lower rates of oxidative energy production even at submaximal intensities (during 
recovery). It should be noted that the beneficial effects of training on muscle, such as 
mitochondrial biogenesis, increased cytochrome oxidase activity, and greater activation 
of mitochondrial complexes has been demonstrated to lead to greater improvements in 
oxygen deficit than EPOC (109). In light of which, the authors pointed out that EPOC is 
less dependent on muscle oxygen consumption than deficit, as it also reflects the slowly 
decreasing oxygen consumption of the heart and lungs among other variables. It is then 
surprising that we found in this study a strong relationship between muscle oxidative 
capacity and EPOC, but not oxygen deficit.  
 An enhanced ability to produce energy oxidatively may also lead to a lesser 
reliance on PCr at the onset of activity, as observed in Aim 1, thus decreasing the amount 
of PCr that needs to be replenished in recovery. Our analysis shows that the strongest 
association among our variables was the positive linear relationship between ∆PCr and 
EPOC (rs = 0.75). This relationship indicates that those who deplete PCr to a greater 
degree at the onset of exercise take longer to recover following exercise, and that reliance 
on non-oxidative energy production at the beginning of exercise may be a more important 
determinant for exercise recovery than oxidative capacity. This is not surprising given 
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that EPOC was originally termed oxygen debt and was believed to only consist of 
‘repayment’ of oxygen deficit; an idea that has since been disproven, but was not entirely 
baseless (38).  
Muscle Oxidative Capacity is Associated with RER 
Muscle oxidative capacity was associated with the mean RER from the entire 
steady-state (RER L23, rs = -0.64), the last 5 min (RER L5, rs = -0.68), and the last 
minute (RER L1, rs = -0.74) of the 30MTW. These correlations suggest that individuals 
with a higher oxidative capacity relied more on fat oxidation than those with a lower 
oxidative capacity throughout the 30MTW. In the example plot in Fig. 27, RER takes 
longer to plateau than does VO2, suggesting that RER changes over the course of VO2 
steady-state; a similar pattern was observed in all participants. It is interesting to note that 
the association between muscle oxidative capacity and RER appears to strengthen when 
the RER mean was calculated from the latter portions of the test, especially considering 
that the group means for RER L23, L5 and L1 were not significantly different (Table. 4).  
Oxidative capacity is more than just a measure of the muscle’s ability to replenish 
PCr, it is an indicator of the tissue's ability to produce ATP through oxidative metabolism 
(87). Fat is the preferred fuel source for oxidative metabolism at rest and during low-
intensity activities. Carbohydrate is the predominant fuel source at higher intensities, at 
least partially because it can be metabolized at a faster rate (55, 90). In this way, cells rely 
more on fat until the energy demand is too great to be met by its slower rate of oxidation. 
A higher oxidative capacity may keep energy demand from reaching this point, which 
would explain the association between oxidative capacity and RER. Likewise, an 
adaptation seen with training is an increase in fat oxidation across relative intensities (13, 
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31). The results here suggest that this effect may be evident even at relatively low 
intensities (i.e., the 30MTW). It is also important to consider that the 30MTW walk 
represented a different relative intensity (as a percentage of VO2 peak) across 
participants. The relationship between muscle oxidative capacity and RER may be a 
function of the higher VO2 peak, and therefore lower relative intensity, in individuals 
with a higher oxidative capacity (14). 
A surprising finding was that ∆PCr had a higher correlation with RER (L23 rs = 
0.75, L5 = 0.71, and L1 = 0.70) than muscle oxidative capacity did. Given that ∆PCr is a 
purely anaerobic measure, and RER (at steady-state) is a purely aerobic measure, the 
reason for this relationship is not clear. However, individuals who had a greater ∆PCr 
also had a lower VO2 peak per lean mass (rs = -0.62); so the relationship between ∆PCr 
and RER may also be an artifact of the relative intensity of the 30MTW. Other factors, 
such as energy balance and dietary consumption, can also affect RER, however this was 
controlled for by the standardized lunch consumed 2.5 hr. before the 30MTW by all 
participants (80). 
Muscle Oxidative Capacity is Associated with VO2 Peak 
 Muscle oxidative capacity was associated with VO2 peak relative to lean mass (rs 
= 0.64), but not VO2 peak relative to total mass (rs = 0.14). This suggests that individuals 
with a higher oxidative capacity tend to have a greater ability to increase whole-body 
oxygen consumption per unit of lean tissue, but not per unit of total mass (fat and lean 
mass); meaning that variations in body fat between participants confound this 
relationship, which is not surprising given the relatively low metabolic rate of adipose 
tissue (32). This is in contrast to several previous studies that have found an association 
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between VO2 peak normalized to total mass and muscle oxidative capacity measured via 
in vitro respiration (r2 = .81-.89) (111), near-infrared spectroscopy (r2 = .57) (63), and 31P-
MRS (r2 = .54) (2). Discrepancies in findings may be due a smaller range in body 
composition (63), or greater number of participants (2, 111), which may have negated or 
balance the impact of inter-individual differences in body composition. In another study 
(58), an inverse relationship was shown- a higher VO2 peak was associated with a slower 
PCr recovery- but this was possibly due to sex based differences in VO2 peak (women 
tend to have a higher percentage of body fat).  It has been suggested that VO2 normalized 
to total body mass may have greater implications for exercise performance, while VO2 
normalized to lean mass (more metabolically active tissue) is more relevant when 
discussing physiological capacity (39).This is logical as an increase in body fat would 
increase the workload of a graded treadmill test, but not mechanical function or oxidative 
capacity of the muscle. 
Maximal oxygen consumption is dependent on the ability of the pulmonary and 
cardiovascular systems to deliver oxygen to the body’s cells, the capacity of those cells to 
use oxygen to generate ATP, and the rate at which ATP production can be stimulated. 
However, studies that have measured oxidative capacity in isolated muscle cells suggest 
that the summed maximal oxygen consumption of all the body’s muscle cells is greater 
than what has been measured at the whole-body level (5, 10).  This suggests that oxygen 
consumption is likely limited by the ability of the body to deliver oxygen to the muscle, 
not the muscle’s oxidative capacity. Despite this, ours and other studies have shown 
evidence of a positive relationship between muscle oxidative capacity and peak oxygen 
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consumption (3). It is reasonable then, that although muscle oxidative capacity may not 
be the factor limiting VO2 peak, it can be used as an indicator for aerobic fitness.  
It should be noted that performance in a graded exercise test and the VO2 peak 
value obtained is dependent on participant motivation, nutritional status, the testing 
environment, exercise experience, and testing modality (e.g., treadmill, cycle ergometer 
.etc.), among other factors (55, 90). If not well controlled, these factors can lead to 
greater variability and lower accuracy in this measure. In addition, performance of a 
graded exercise test may not be possible for certain populations, including the elderly. 
Due to this, Alexander et al., 2003 (4) suggest that submaximal measures of oxygen 
consumption such as the oxygen deficit and EPOC may be more suitable indicators of 
aerobic fitness in these populations. This is one of the reasons that Aims 2.1 and 2.2 
focused on submaximal whole-body measurements that minimize or eliminate some of 
these issues in identifying the link between muscle and whole-body energetics. 
Limitations 
This study was completed on a small number of participants, who were all male, 
younger, relatively healthy, and not representative of the population as a whole. This 
could be easily remedied through a study with a greater number of participants including 
both sexes and multiple age groups. With the 7 or 8 participants involved in these 
analyses, a Spearman’s rs greater than ~0.76 would have been necessary to reach the 
generally accepted alpha level of significance of p < 0.05. No associations detected here 
met that criterion. Again, a greater number of participants could help with this. Since this 
was an exploratory study, associations were also assessed using Pearson’s and Kendall’s 
methods and these data can be found in Appendix E. Pearson correlations resulted in 
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considerably higher coefficients and lower p-values and the opposite was true for 
Kendall’s. Oxygen consumption data is inherently subject to a fair amount of variability 
and noise. As a result completing several 30MTWs and averaging the oxygen 
consumption measurements would have been useful for increasing the signal to noise 
ratio. A study by Benson et al. in 2017 (11), specifically suggests averaging four exercise 
bouts when analyzing the oxygen deficit, and even proposed a minimally important time 
constant difference of ~5 s (which was not found in our study). As mentioned in the 
results, the timing of the end of the 30MTW was not recorded for two participants, and 
thus had to be estimated. The first four participants were allowed phone access during 
recovery, which may have unintentionally increased VO2 during this period. Several 
participants who were not allowed phone access during recovery were close to falling 
asleep post-walk, which may have unintentionally decreased their resting VO2. If this 
study were repeated, better control of the environment, wakefulness of participants, and 
timing of the whole-body energetic measurements would be desirable. To account for the 
thermic effect of food and other dietary responses a standardized lunch was fed to 
participants for all visits. This lunch, however, may not have the same effect on 
participants with different body sizes, free-living diets, and energy expenditures. 
Individualization of future standardized meals may be more effective if robust methods to 
elicit similar responses can be implemented. 
Summary 
The goal of this study was to investigate both non-oxidative and oxidative 
energetic characteristics at the muscle and whole-body levels. Associations were 
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observed between ∆PCr and oxygen deficit, EPOC, and RER; as well as between muscle 
oxidative capacity and EPOC, RER, and VO2 peak in a group of healthy, young males.  
These promising results can be extended by studies evaluating the same 
relationships with participants of different ages, sex, and habitual physical activity levels. 
If strong and significant associations are consistently demonstrated, then researchers can 
begin to make inferences about whole-body energetics from muscle measurements, and 
vice versa. There is already a well-established relationship between whole-body 
energetics - including oxygen deficit, EPOC, and VO2 peak, and energy cost of walking – 
and performance and fatigability during mobility test (4, 9, 92, 98, 99). Therefore, whole-
body energetics may serve as an intermediary point between muscle energetics and 
mobility-related function. This connection could potentially help researchers understand 
the role muscle energetics may play in the decline in mobility-related function (Fig. 41). 
This would be particularly useful in the study of aging and physical inactivity, which is 
associated with a decline in knee extensor muscle oxidative capacity (36), as well as a 
decline in walking speed, postural control, and the ability to transition from sitting to 
standing or walking (9, 11, 75). 
 
Figure 41. Pathway connecting muscle energetics to mobility-related 
function. Adapted from Fig. 2. 
 
In conclusion, this study provides preliminary evidence that muscle energetics are 
indicative of the oxygen deficit, RER, and EPOC in response to daily-living type 
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exercise. This is a novel finding that links muscle and whole-body energetics despite their 
being measured using different techniques, in different settings, and in response to 
different forms of exercise. Given the practicality of indirect calorimetry measurement 
during mobility tasks, this link can be exploited to improve our understanding of the 





INFORMED CONSENT FORM 
Consent Form for Participation in a Research Study University of Massachusetts 
Amherst 
Researcher(s): Michael Busa, Ph.D.,  Jane Kent, Ph.D., John Sirard, Ph.D., John 
Staudenmayer, Ph.D., Greg Petrucci, Christopher Hayden 
Study Title: Room Calorimetry: Energetics of Fatigue Pilot 
Funding Agency:  
1. WHAT IS THIS FORM? 
This form is called a Consent Form. It will give you information about the study so you 
can make an informed decision about participation in this research. It will also describe 
what you will need to do to participate and any known risks, inconveniences or 
discomforts that you may have while participating. We encourage you to take some time 
to think this over and ask questions now and at any other time. If you decide to 
participate, you will be asked to sign this form and you will be given a copy for your 
records. 
2. WHO IS ELIGIBLE TO PARTICIPATE? 
We are recruiting 8 people to participate in this study. All participants will be free of 
acute and chronic neurological, musculoskeletal, metabolic, cardiovascular or other major 
diseases or injuries, and will not have a pacemaker. Additionally, a physician must not 
have told the participant that they should refrain from physical activity. Additionally, 
they will not have had surgery in the previous 6 months that would impact their ability to 
perform light-to-moderate physical activity. Participants will consist of 8 males between 
the ages of 25-40 years. 
3. WHAT IS THE PURPOSE OF THIS STUDY? 
The goals of this study are to: 1) Demonstrate that reliable data can be obtained from the 
Room Calorimeter during 24-hour visits. 2) Determine the sensitivity of the Room 
Calorimeter system to better understand its capacity and constraints. 3) Compare energy 
expenditure values from the Room Calorimeter to energy expenditure and physical 
activity estimates from several research-grade accelerometers. 4) Identify the effects of a 
treadmill walk on the energetics of healthy young sedentary individuals. 5) Collect data 
that will assist us in developing hypotheses in the areas of exercise, exercise recovery, 
mechanical and metabolic interactions, and physical activity assessment. 




The study will be conducted in the Human Testing Center and the Human Magnetic 
Resonance Center (S360 and S230 Life Science Laboratory Building), in the Institute for 
Applied Life Science (IALS) at the University of Massachusetts Amherst. This study is 
expected to last 18 months. If you participate, you will take part in 4 testing visits; 2 
visits will last approximately 24 hours each, 1 visit will last 4.5 hours, and 1 visit will last 
2.5 hours. 
 
5. WHAT WILL I BE ASKED TO DO? 
Prior to each visit 
 We ask that the day prior to each visit you avoid alcohol use and strenuous 
exercise. The day of each visit we also ask that you avoid consuming caffeine. 
Visit 1 (4.5-hour Baseline Habituation visit) 
This visit will be conducted in the Room Calorimeter suite of the Human Testing Center 
in IALS, with the exception of height and weight measures and the body composition 
scan, which will be completed across the hall in the Exam Room. The Room Calorimeter 
is an instrument built as a standard room and used to measure oxygen consumption and 
carbon dioxide production by humans in a typical living setting. It is about the size of a 
large bedroom and contains a TV, toilet, sink, chair, desk, and treadmill. There are two 
ports (sealed openings in the wall) by the entrance to the room that are used for passing 
food and other material into the chamber without opening the doors. The room has a 
window to the outside of the building as well as to the inside of the lab. Both windows 
are equipped with blinds for privacy. For the first visit, the Room Calorimeter door will 
not be shut and the instrument will not be running. This habituation visit will allow you 
to become familiar with the facility, and promote easier acclimation during following 
visits. 
You will be fed a small lunch (~400 calorie meal replacement bar) which will allow us to 
compare energetic response between participants, there will be several options to choose 
from. You will be allowed 30 minutes to complete your lunch. You will be oriented to the 
Room Calorimeter, and shown the button that blurs the cameras in case you are in need 
of private time (i.e., changing clothes or using the toilet). Video will be recorded during 
this study, this button will disable recording and live viewing through the camera system. 
Video access is restricted to Human Testing Center personnel and can only be accessed 
using an onsite computer. You will also be shown how to work the exit door (a simple 
push latch). Your height, weight, age, and gender will be recorded, and an iDXA body 
scan will be completed by a certified technician.  
iDXA Scan 
An iDXA (dual-energy X-ray absorptiometry) scan, also called a bone density scan, is a 
common technique used to measure bone density. It can also be used to estimate body 
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composition (% fat and % lean mass), as in this study. The DXA scan will involve lying 
on a padded table while a scanning arm passes over you. This test will last no longer than 
30 minutes. This completely painless procedure is easily performed and involves minimal 
radiation exposure. 
 In accordance with Massachusetts Department of Public Health guidelines, iDXA scans 
are performed by a certified technician and prescribed and reviewed by Dr. Stuart 
Chipkin (University of Massachusetts Amherst, 240 Thatcher Rd., Amherst, MA 01003). 
During the scan you will be exposed to low amounts of ionizing radiation; these levels 
are approximately 2% of that you would be exposed to during a chest X-Ray and less 
than you would receive from a cross-country airplane flight. 
From this study, it may be found that you have ‘normal bone density’, ‘low bone 
density’, ‘osteoporosis’, or ‘severe osteoporosis’. If your results indicate anything 
OTHER THAN ‘normal bone density,’ you will receive a follow-up letter from the 
research team. In this case, it will be recommended that you follow up with your personal 
physician. With your written permission, the data that we collect will be made available 
to your physician for their review and interpretation. These results are not diagnostic and 
do not indicate a specific risk of bone fracture. This can only be determined by a clinician 
when also accounting for other factors. 
Prior to this scan, you will be asked a series of screening questions to determine if 
undergoing an iDXA would pose any undue risk. As this is for your protection, it is of the 
utmost importance that you answer completely and to the best of your knowledge. While 
the risk with this procedure is extremely low, your safety is paramount.  
 
Two hours after lunch you will be outfitted with the Parvo Medics TrueOne 2400 
Metabolic System, which consist of a mask connected to hoses that collect expired air, 
filters it, and runs it through a gas analyzer on a stationary cart. You will be asked initiate 
the fitting of the mask and a researcher (while wearing gloves and a face shield) will step 
in to complete it. You will also be asked to outfit yourself with several research-grade 
accelerometers (similar to Fitbits); an ActivPal (dominant thigh), a StepWatch (dominant 
ankle), a SenseWear Armband (upper arm), and an ActiGraph (non-dominant wrist). 
Next, you will be asked to complete 30 minutes of walking on a treadmill. The treadmill 
will be flat and the speed will be increased over the first 30 seconds of this walk until 1.3 
m∙s-1 is reached. At that point, you will be asked if you think you can maintain that speed 
for 30 minutes. If you cannot, the treadmill speed will be reduced in small (0.045 meters 
per sec) increments every 10 seconds, until you are confident you are at a speed that you 
can maintain for 30 minutes. At minutes 7, 17, and 27, the incline of the treadmill will be 
increased to 3% for 1 minute, in order to provide a slight challenge and to simulate a hill 
that you might encounter in everyday life. After 1 minute, the incline will be returned to 
level. At minute 28, you will be asked to rate your exertion on a scale of 0 to 10. The 
scale is a simple visual rating system that you can point to during the walk, with a 0 
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meaning “nothing at all” and a 10 meaning “maximal” exertion. During the final 30 
seconds of the walk, the treadmill will be gradually slowed to 0.4 meters per second 
before stopping.  
During this treadmill walk, you will be connected to the emergency stop safety cord and 
instructed on how to use the treadmill safely. At all times, the treadmill will be controlled 
by study staff. This treadmill walk will be completed on the treadmill in the Room 
Calorimeter. 
Next, you will be asked to sit quietly for a 2-hour, passive recovery period during which 
time you will be allowed to watch TV, read, or use any mobile devices you may have. 
You will wear all of the same study devices from the walk during this recovery period. 
After this passive recovery, you will remove the facemask and all other monitors. You 
will then be given an ActiGraph (a step counter), which you will be asked to wear on 
your non-dominant wrist for a seven-day lead-up to your first 24-hour visit to the Room 
Calorimeter. You will also be asked to take pictures of your meals and any snacks for 3 
days prior to your second visit. You will be asked to complete this task and send us the 
pictures via email at least two days before your 24-hour visit.  
 
Visits 2 and 3 (24-hour Room Calorimeter Stays):  
You will be asked to complete two visits of 24 hours each in the Room Calorimeter. They 
will be completed on separate days within one month of each other. These visits will be 
conducted in the Room Calorimeter suite of the Human Testing Center of IALS. 
 You will be asked to arrive in the evening (~7 pm). Upon arrival, you will again 
outfit yourself with Fitbit-like devices consisting of an ActivPal (placed on your 
dominant thigh), a StepWatch (dominant ankle), a SenseWear Armband (upper arm), and 
an ActiGraph (non-dominant wrist). You will be asked to keep these on for the duration 
of the study unless you are changing your clothes.  
The Room Calorimeter is an instrument that allows us to measure your oxygen 
consumption. This measurement requires the door to the room calorimeter to remain 
sealed throughout the study. You will be free to leave at any time during the study if you 
no longer wish to be a participant. You should simply notify the study staff and press on 
the exit latch to leave the room. Your entire stay will be video recorded through the 
cameras installed in the calorimeter, sound will not be recorded. We will use these 
recording to annotate your stay and the timing of certain activities you will perform. You 
can stop the video from recording at any time by pressing a button on the wall. We will 
request that you do this anytime you wish to change, use the restroom, or are in need of 
private time. 
A walkie-talkie (and extra batteries) will be provided and there will be a CPR- and First 
Aid-certified research staff member in communication with you at all times. A schedule 
will be given to you, and either the walkie-talkie or the intercom system will be used to 
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provide further instructions during your stay. You will then enter the Room Calorimeter. 
The schedule is as follows: 
7:00 PM:  Enter Room Calorimeter and quick review of facilities and procedures 
7:15 PM: Dinner (served through the food port) 
8:00 PM:  Free time until you wish to sleep 
12:00 AM:  Time by which you must be in bed  
8:00 AM:  Wake up, get out of bed 
8:15 AM: Scripted Activities (see below)  
9:15 AM:  Breakfast (served through the food port) 
9:45 AM:  Downtime 
11:30 AM:  Lunch 
12:00 PM:  Two hours of passive (resting) free time 
2:00 PM:  30 treadmill walk as described above (without Parvo unit) 
2:30 PM:  Passive recovery 
7:00 PM:  Exit Room Calorimeter 
 
The “Scripted Activities” will be as follows 
 Strip bed; make bed (10 min) 
 Sit (5 min) 
 Fold basket of laundry (towels; 10 min) 
 Sit (5 min) 
 Vacuum floor (10 min) 
 Sit (5 min) 
 Wash and dry dinnerware and silverware (10 min) 
 Sit (5 min) 
 
You will be asked to complete 1,200 steps in the Room during your downtime (before 
2:00 pm). The activity tracker on your wrist will display the step count for you. Breakfast 
and dinner will be based on the meal pictures you provided us. Lunch will be the same 
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for all four visits. After exiting the Room Calorimeter, you will remove all devices prior 
to leaving. 
Research staff will be present in the Human Testing Center for the entirety of the study 
(including during your sleep time). 
Visits 4 (Exercise Testing):  
For Visit 4 you will be given a meal replacement bar ahead of time to take home, 
identical to the other visits, which we ask you consume in the morning two hours before 
your visit. That morning you will also be asked to: 
1. Wear loose-fitting clothes (jogging attire, shorts, training shoes, etc.)  
2. Avoid eating or drinking anything but water and the meal provided. 
3. Avoid alcohol, tobacco, and coffee.  
4. Avoid exercising.  
5. Try to get a good night's sleep the night before.  
Upon arriving at the Human Magnetic Resonance Center in the Life Sciences Lab 
Building, you will meet with the MR Operator to review the MR Safety Form. Before 
entering the magnet room, you will remove any jewelry, empty your pockets, and walk 
through a metal detector. You will then be escorted to the MR scanner and positioned on 
your back with your dominant leg on top of our custom-built leg exercise apparatus, 
which is similar to a knee extension machine one might use at a gym. The lower leg 
(shin) will be strapped to the apparatus just above the ankle and at the knee using Velcro 
straps. Inelastic straps will also be secured over your hips to prevent unwanted movement 
during the muscle contractions, and a specially-designed copper coil encased in a plastic 
box will be secured over your thigh muscles using Velcro straps. This coil will be used to 
measure changes in muscle biochemistry during the contractions. 
Lastly, headphones will be provided to limit the amount of noise from the MR scanner, 
and to enable clear and constant communication between you and the investigators. We 
will talk with you and explain each set of measures as we go along.  These measures are 
described next. 
After you have been secured to the leg-exercise apparatus, we will position you in the 
center of the scanner and “tune” the magnet to your thigh muscles. We will then take 
measures of your muscle biochemistry while you lay quietly for about 10-15 minutes. 
Next, you will complete 2-3 maximal static contractions, each lasting 3-4 seconds, to 
determine your strength and to establish the workloads that will be performed during the 
incremental protocol. About 1 minute of rest will be given between each of these 
contractions.  You will then be familiarized with the dynamic contractions (1 contraction 
every 2 seconds) by performing a few sets of 2-3 contractions. Once you are comfortable 
with the dynamic contraction procedures, you will perform a 24s maximal isokinetic 
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contraction protocol. This will consist of one maximal dynamic contraction every two 
sections, after which you will rest quietly without moving for up to 10 minutes. 
Next, you will perform the study protocol, which involves 4 stages of dynamic knee 
extensions. These contractions are most similar to the types of contractions that would be 
performed on an exercise machine at a fitness gym. Each stage will last 2 minutes, with 1 
contraction being performed every 2 seconds. Workload will increase with each stage, 
starting at a light intensity and increasing to moderately-high intensity. Following the 4th 
stage of the protocol, recovery measures will be collected while you rest quietly without 
moving for up to 10 minutes. Following the MR measures, you will be brought from the 
Human Magnetic Resonance Center to the Human Testing Center. In the human testing 
center, you will have your blood pressure taken and will be prepped to complete a graded 
exercise test to determine your maximal volume of oxygen consumption (VO2 max).  
VO2 max tests are one of the most widely used evaluations in the world of exercise 
physiology and are utilized to evaluate aerobic fitness. During the test, you will be 
instrumented with the same Parvo Metabolic Cart utilized during the baseline visit as 
well as a chest strap Polar heart rate monitor. We will be using the BSU/Bruce Ramp 
treadmill protocol as described by Kaminsky and Whaley (1998). This protocol is 
designed to be better suited for a wide range of populations through its use of a gradual 
ramp in intensity, allowing for longer walking periods and smaller transitions between 
stages. The test begins with a paced walk and gradually increases in speed and/or incline. 
Heart rate, oxygen consumption, and Rating of Perceived Exertion (RPE) will be 
monitored throughout the test. The test will be terminated when you feel you cannot 
continue or if the researcher determines the test should end due to maximal intensity 
being reached safety concerns or equipment malfunction. A typical test will last between 
8-12 minutes depending on your fitness level. After Completion of the VO2 max test, you 
will have equipment removed and will complete a short cool down.  
6. WHAT ARE MY BENEFITS FOR BEING IN THIS STUDY? 
It is important that you understand that we anticipate no direct benefit to you from your 
participation in this study.  
7. WHAT ARE MY RISKS OF BEING IN THIS STUDY? 
Physical well-being 
General Exercise Precautions: During any type of exercise, there are slight health risks, 
along with the possibility of fatigue, cardiovascular events, muscle soreness, and falls. 
Study personnel will monitor your performance. The testing will be terminated if you 
show any signs of poor exercise tolerance (i.e. extreme fatigue, shortness of breath, chest 
pain, dizziness, etc.).  
VO2 Max Testing: Risk include, but are not limited to, abnormal blood pressure, chest 
pain, shortness of breath, fainting, disorders of the heartbeat (too rapid, too slow or 
unusual beats) and in rare instances, heart attack. Every effort will be made to avoid or 
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minimize such occurrences through screening and continuous observations during testing. 
Emergency equipment and trained personnel are available to deal with unusual situations 
which may arise. 
DXA Scan: Scans expose you to low-levels of X-Ray ionizing radiation. The risk 
associated with this type of scan is very low, less than that of a New York to Los Angeles 
flight. You will be screened for the possibility of lifetime limit for radiation exposure. If 
you indicate that you have reached their lifetime limit for being exposed to ionizing 
radiation, then no scan will be performed. 
Magnetic Resonance Spectroscopy (MRS) and Imaging (MRI): The United States Food 
and Drug Administration (FDA) has established guidelines for magnetic field strength 
and exposure to radio waves, and we carefully observe those guidelines. Some people 
may feel uncomfortable or anxious during the MRS testing procedures. If this happens 
you may ask to stop the study at any time and we will take you out of the MR scanner 
(magnet). On rare occasions, some individuals might feel dizzy, get an upset stomach, 
have a metallic taste, feel tingling sensations, or experience muscle twitches. MRS poses 
some risks for certain people. Individuals with a pacemaker or some metal object inside 
the body will be excluded from this study because of the strong magnets used for these 
studies. Another risk is a metallic object flying through the air toward the magnet and 
hitting the participant. To reduce this risk we require that all people involved with the 
study remove all metal from their clothing and all metal objects from their pockets. 
Nothing metal can be brought into the magnet room at any time. Also, once you are in the 
magnet, the door to the room will be closed so that no one from outside accidentally goes 
near the magnet. 
Psychological well-being 
During the 24-hour stay, you will be asked to stay within the Room Calorimeter, which is 
very similar to a hotel room. Because of the duration and lack of general outside contact, 
you may become bored. To minimize this you will have access to all modern means of 
personal communication and entertainment (i.e. phone, computer, TV, internet access). 
Visitors will also be allowed during your downtime, however, they must remain outside 
of the chamber. Being in the Room Calorimeter may make you feel uncomfortable, 
anxious, or claustrophobic, although multiple windows in this space minimize this 
possibility. 
You may be bothered by feelings of claustrophobia during MRS testing. Unlike the case 
for brain imaging, you will be positioned feet-first in the magnet, and your head will 
remain near the opening of the magnet. These features minimize the problem of 
claustrophobia, but anyone reporting significant claustrophobia who wishes to be 
removed from the scanner will be removed immediately. 
8. HOW WILL MY PERSONAL INFORMATION BE PROTECTED? 
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All digital files will be maintained on an encrypted, secure, password-protected server. 
None of your personal information will be included in these files. Rather, we will give 
them a code. The file linking your identity and code will be kept in a locked drawer in a 
locked room. We expect the data collection for this study to last approximately 1.5 years. 
All electronic files containing identifiable information will be password-protected. Video 
recordings will be housed on a secure data server and agents of the sponsor may be able 
to view these on-site at UMass. At the conclusion of this study, the researchers may 
publish their findings. Information will be presented in summary format and you will not 
be personally identified in any publications or presentations. 
9. WHAT IF THERE IS AN UNEXPECTED FINDING ON MY IDXA OR 
MRI SCAN? 
The investigators for this research project are not licensed or trained diagnosticians or 
clinicians. The testing performed in this project is not intended to find abnormalities, and 
the images or data collected do not comprise a diagnostic or clinical study. However, 
occasionally in the process of research, investigators may perceive an abnormality, the 
health implications of which may not be clear.  When an unexpected finding is noted, 
UMASS Amherst researchers will consult with a radiologist (for MRI) or physician (for 
iDXA).  If the radiologist/physician determines that an additional inquiry is warranted, 
the researcher will then contact you regarding the radiologist’s/physician’s opinion of the 
unexpected finding(s). 
In such a case, you are advised to consult with a licensed physician to determine whether 
further examination or treatment would be prudent. Although the images collected for 
this research project do not comprise a diagnostic or clinical study, the images can be 
made available to you for clinical follow-up. The costs for any care that will be needed to 
diagnose or treat an unexpected finding(s) would not be paid for by University of 
Massachusetts, Amherst.  These costs would be your responsibility. If you have further 
tests done by your licensed physician, those results will then become part of your medical 
record, which may affect your current and future health or life insurance. Regardless of 
the health implications, the discovery of an unexpected finding(s) may cause you to feel 
anxious or worried. You may wish to talk to your physician or a qualified mental health 
clinician. You can contact the Center for Counseling and Psychological Health (CCPH) 
at (413) 545-2337 (Mon-Fri from 8-5pm) - on weekends or after 5pm, call (413) 577-
5000 and ask for the CCPH clinician on call. You can also contact the Psychological 
Services Center at 413-545-0041 (Monday-Friday 8am-5pm) or psc@psych.umass.edu. 
In a serious emergency, remember that you can also call 911 for immediate assistance. 
 
10. WILL I RECEIVE ANY PAYMENT FOR TAKING PART IN THE 
STUDY? 
Yes, you will be compensated in person for your participation in this study, in gift cards. 
You will receive $25 for the baseline visit, $100 for each 24-hour visit, and $25 for the 
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exercise testing visit. You will be paid at the end of each portion of the study. Payment 
for the 24-hour stay will be prorated in six-hour increments. You will receive $25 for 
each 6-hour block you stay in the study (e.g., those who drop out after 12 hours will 
receive $50). You will receive the full $100 if and when you complete the full 24-hour 
visit. Total possible compensation will equal $250. 
11. WHAT IF I HAVE QUESTIONS? 
Take as long as you like before you make a decision about whether to participate. We 
will be happy to answer any question you have about this study. If you have further 
questions about this project or if you have a research-related problem, you may contact 
the principal investigator, Professor Jane Kent (413-545-9477; jkent@umass.edu). If you 
have any questions concerning your rights as a research subject, you may contact the 
University of Massachusetts Amherst Human Research Protection Office (HRPO) at 
(413) 545-3428 or humansubjects@ora.umass.edu. 
12. CAN I STOP BEING IN THE STUDY? 
You do not have to be in this study if you do not want to. If you agree to be in the study, 
but later change your mind, you may drop out at any time. There are no penalties or 
consequences of any kind if you decide that you do not want to participate. 
13. WHAT IF I AM INJURED? 
The University of Massachusetts does not have a program for compensating subjects for 
injury or complications related to human subjects research, but the study personnel will 
assist you in getting treatment in the unlikely event that you are injured during the testing. 
14. CAN WE RECONTACT YOU? 
May we contact you in the future to invite you to participate in additional studies like this 
one? 
Yes NO 
15. SUBJECT STATEMENT OF VOLUNTARY CONSENT 
When signing this form, I am agreeing to voluntarily enter this study. I have had a chance 
to read this consent form, and it was explained to me in a language that I use and 
understand. I have had the opportunity to ask questions and have received satisfactory 
answers. I understand that I can withdraw at any time. A copy of this signed Informed 
Consent Form has been given to me.  
In no way does signing this consent form waive your legal rights nor does it relieve the 
investigators, sponsor or involved institutions from their legal and professional 
responsibilities. 
Participant Signature 




By signing below, I indicate that the participant has read and, to the best of my 
knowledge, understands the details contained in this document and has been given a 
copy. 
 
Signature of Person Obtaining Consent 
Print Name  
Date 
EMERGENCY CONTACT 
As a part of this study, you will be staying in the Human Testing Center for 24 hours. In 
the event that you fall ill or become injured, please provide an emergency contact. 
Emergency Contact Name  





























PARTICIPANT 7 EPOC FIT DATA ADJUSTMENT FOR PHONE USE 
 
Figure 42. Screenshot of the curve fitting analysis for 30MTW EPOC of participant 
7. Data are VO2 fit over time from a single participant (pt7). Offy, volume of oxygen 
consumption in mL∙kg-1∙min-1; offx, time in seconds; 30MTW, 30-min treadmill walk. 
A.) Unadjusted fit of EPOC. 
B.) Adjusted fit EPOC. Data points during documented times when the participant was 
observed to be holding a cellular phone high in front of their face (red “x’s”) were 
excluded from the fit. The results from this fit were used for analysis in this case. It is 
likely that phone use in this manner occurred with earlier participants, as well. However, 
the exact times of this use were not documented, and therefore, those data were not 






CORRELATION COEFFICIENTS AND P-VALUES FROM PEARSON’S, 
SPEARMAN’S, AND KENDALL’S TESTS 
 








∆PCr (mM) 1.00 1.00 1.00 1.00 1.00 1.00 
Oxygen Deficit (s) 0.68 0.09 0.46 0.30 0.33 0.38 
Oxidative Capacity 
(s-1) 
-0.73 0.04 -0.62 0.11 -0.43 0.18 
RER L23 0.75 0.05 0.75 0.07 0.62 0.07 
RER L5 0.80 0.03 0.71 0.09 0.52 0.14 
RER L1 0.76 0.05 0.70 0.09 0.59 0.09 
EPOC (s) 0.57 0.18 0.75 0.07 0.62 0.07 
VO2 Peak  
(mL∙kg-1∙min-1) 
-0.38 0.35 -0.52 0.20 -0.36 0.28 
VO2 Peak Lean 
(mL∙kg-1 lean∙min-1) 
-0.61 0.10 -0.62 0.11 -0.43 0.18 
 








∆PCr (mM) -0.73 0.04 -0.62 0.11 -0.43 0.18 
Oxygen Deficit (s) -0.24 0.60 -0.18 0.71 -0.14 0.77 
Oxidative Capacity 
(s-1) 
1.00 1.00 1.00 1.00 1.00 1.00 
RER L23 -0.65 0.11 -0.64 0.14 -0.43 0.24 
RER L5 -0.76 0.05 -0.68 0.11 -0.52 0.14 
RER L1 -0.90 0.01 -0.74 0.07 -0.59 0.09 
EPOC (s) -0.74 0.06 -0.64 0.14 -0.43 0.24 
VO2 Peak  
(mL∙kg-1∙min-1) 
0.23 0.58 0.14 0.75 0.21 0.55 
VO2 Peak Lean 
(mL∙kg-1 lean∙min-1) 
0.63 0.09 0.64 0.10 0.43 0.18 
EPOC, excess post-exercise oxygen consumption; RER, respiratory exchange ratio; RER 
L23, average RER over the last 23 min of walk; RER L5, average RER over the last 5 
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